Select Medical (SEM) 10-Q 2011 Q3 Quarterly report

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

þ  Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarterly Period Ended September 30, 2011

o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Transition Period From                    to                    .

Commission File Numbers:001 — 34465 and 001 — 31441

SELECT MEDICAL HOLDINGS CORPORATION

SELECT MEDICAL CORPORATION

(Exact name of Registrants as specified in their charters)

Delaware	20-1764048
Delaware	23-2872718
(State or other jurisdiction of	(I.R.S. employer identification number)
incorporation or organization)

4714 Gettysburg Road, P.O. Box 2034, Mechanicsburg, Pennsylvania 17055
(Address of principal executive offices and zip code)

(717) 972-1100
(Registrants’ telephone number, including area code)

Indicate by check mark whether the Registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periods as the Registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days.

YESþ NOo

Indicate by check mark whether the Registrants have submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the Registrants were required to submit and post such files).

YESþ NOo

Indicate by check mark whether the Registrants are large accelerated filers, accelerated filers, non-accelerated filers, or smaller reporting companies. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filerso Accelerated filersþ Non-accelerated filerso Smaller reporting companyo

Indicate by check mark whether the Registrants are shell companies (as defined in Rule 12b-2 of the Exchange Act).

YESo NOþ

As of October 31, 2011, Select Medical Holdings Corporation had outstanding 148,108,130 shares of common stock.

This Form 10-Q is a combined quarterly report being filed separately by two Registrants: Select Medical Holdings Corporation and Select Medical Corporation. Unless the context indicates otherwise, any reference in this report to “Holdings” refers to Select Medical Holdings Corporation and any reference to “Select” refers to Select Medical Corporation, the wholly-owned operating subsidiary of Holdings. References to the “Company,” “we,” “us,” and “our” refer collectively to Select Medical Holdings Corporation and Select Medical Corporation.

TABLE OF CONTENTS

PART I FINANCIAL INFORMATION	3
ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS
Consolidated balance sheets	3
Consolidated statements of operations	4
Consolidated statements of changes in equity and income	6
Consolidated statements of cash flows	7
Notes to consolidated financial statements	8
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	30
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	54
ITEM 4. CONTROLS AND PROCEDURES	55
PART II OTHER INFORMATION	55
ITEM 1. LEGAL PROCEEDINGS	55
ITEM 1A. RISK FACTORS	56
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	56
ITEM 3. DEFAULTS UPON SENIOR SECURITIES	57
ITEM 4. REMOVED AND RESERVED	57
ITEM 5. OTHER INFORMATION	57
ITEM 6. EXHIBITS	57
SIGNATURES	57
Exhibit 31.1
Exhibit 31.2
Exhibit 32.1
EX-101 INSTANCE DOCUMENT
EX-101 SCHEMA DOCUMENT
EX-101 CALCULATION LINKBASE DOCUMENT
EX-101 LABELS LINKBASE DOCUMENT
EX-101 PRESENTATION LINKBASE DOCUMENT
EX-101 DEFINITION LINKBASE DOCUMENT

2

PART I FINANCIAL INFORMATION

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

Consolidated Balance Sheets

(unaudited)

(in thousands, except share and per share amounts)

	Select Medical Holdings Corporation				Select Medical Corporation
	December 31,		September 30,		December 31,		September 30,
	2010		2011		2010		2011
ASSETS
Current Assets:
Cash and cash equivalents	$	4,365	$	10,213	$	4,365	$	10,213
Accounts receivable, net of allowance for doubtful accounts of $44,416 and $50,597 in 2010 and 2011, respectively		353,432		394,989		353,432		394,989
Current deferred tax asset		30,654		19,834		30,654		19,834
Prepaid income taxes		12,699		10,340		12,699		10,340
Other current assets		28,176		28,106		28,176		28,106
Total Current Assets		429,326		463,482		429,326		463,482
Property and equipment, net		532,100		505,894		532,100		505,894
Goodwill		1,631,252		1,627,509		1,631,252		1,627,509
Other identifiable intangibles		80,119		72,448		80,119		72,448
Assets held for sale		11,342		11,342		11,342		11,342
Other assets		37,947		70,435		35,433		68,937
Total Assets	$	2,722,086	$	2,751,110	$	2,719,572	$	2,749,612
LIABILITIES AND EQUITY
Current Liabilities:
Bank overdrafts	$	18,792	$	14,618	$	18,792	$	14,618
Current portion of long-term debt and notes payable		149,379		10,268		149,379		10,268
Accounts payable		74,193		88,942		74,193		88,942
Accrued payroll		63,760		70,917		63,760		70,917
Accrued vacation		46,588		48,243		46,588		48,243
Accrued interest		30,937		5,590		21,586		5,153
Accrued restructuring		6,754		5,608		6,754		5,608
Accrued other		103,856		105,053		116,456		105,053
Due to third party payors		5,299		4,249		5,299		4,249
Total Current Liabilities		499,558		353,488		502,807		353,051
Long-term debt, net of current portion		1,281,390		1,397,418		974,913		1,230,118
Non-current deferred tax liability		59,074		68,399		59,074		68,399
Other non-current liabilities		66,650		73,219		66,650		73,219
Total Liabilities		1,906,672		1,892,524		1,603,444		1,724,787
Stockholders’ Equity:
Common stock of Holdings, $0.001 par value, 700,000,000 shares authorized, 154,519,025 shares and 149,936,594 shares issued and outstanding in 2010 and 2011, respectively		155		150		—		—
Common stock of Select, $0.01 par value, 100 shares issued and outstanding		—		—		0		0
Capital in excess of par		535,628		518,295		834,894		846,806
Retained earnings		248,097		307,648		249,700		145,526
Total Select Medical Holdings Corporation and Select Medical Corporation Stockholders’ Equity		783,880		826,093		1,084,594		992,332
Non-controlling interest		31,534		32,493		31,534		32,493
Total Equity		815,414		858,586		1,116,128		1,024,825
Total Liabilities and Equity	$	2,722,086	$	2,751,110	$	2,719,572	$	2,749,612

The accompanying notes are an integral part of these consolidated financial statements.

3

Consolidated Statements of Operations

(unaudited)

(in thousands, except per share amounts)

	Select Medical Holdings Corporation						Select Medical Corporation
	For the Three Months Ended September 30,						For the Three Months Ended September 30,
	2010			2011			2010			2011
Net operating revenues	$	588,250		$	694,131		$	588,250		$	694,131
Costs and expenses:
Cost of services		498,739			581,829			498,739			581,829
General and administrative		19,228			14,975			19,228			14,975
Bad debt expense		11,317			11,709			11,317			11,709
Depreciation and amortization		17,012			17,545			17,012			17,545
Total costs and expenses		546,296			626,058			546,296			626,058
Income from operations		41,954			68,073			41,954			68,073
Other income and expense:
Equity in earnings (losses) of unconsolidated subsidiaries		(186	)		1,653			(186	)		1,653
Other income		148			—			148			—
Interest income		—			119			—			119
Interest expense		(27,677	)		(24,134	)		(20,821	)		(21,526	)
Income before income taxes		14,239			45,711			21,095			48,319
Income tax expense		5,574			19,330			7,974			20,243
Net income		8,665			26,381			13,121			28,076
Less: Net income attributable to non-controlling interests		656			785			656			785
Net income attributable to Select Medical Holdings Corporation and Select Medical Corporation	$	8,009		$	25,596		$	12,465		$	27,291
Income per common share:
Basic	$	0.05		$	0.17
Diluted	$	0.05		$	0.17

The accompanying notes are an integral part of these consolidated financial statements.

4

Consolidated Statements of Operations

(unaudited)

(in thousands, except per share amounts)

	Select Medical Holdings Corporation						Select Medical Corporation
	For the Nine Months Ended September 30,						For the Nine Months Ended September 30,
	2010			2011			2010				2011
Net operating revenues	$	1,752,940		$	2,086,066		$	1,752,940			$	2,086,066
Costs and expenses:
Cost of services		1,441,160			1,708,911			1,441,160		��		1,708,911
General and administrative		41,819			47,656			41,819				47,656
Bad debt expense		31,449			40,002			31,449				40,002
Depreciation and amortization		51,333			52,766			51,333				52,766
Total costs and expenses		1,565,761			1,849,335			1,565,761				1,849,335
Income from operations		187,179			236,731			187,179				236,731
Other income and expense:
Loss on early retirement of debt		—			(31,018	)		—				(20,385	)
Equity in earnings (losses) of unconsolidated subsidiaries		(186	)		1,329			(186	)			1,329
Other income		464			—			464				—
Interest income		—			286			—				286
Interest expense		(86,998	)		(75,094	)		(66,184	)			(59,882	)
Income from operations before income taxes		100,459			132,234			121,273				158,079
Income tax expense		39,989			56,809			47,274				65,854
Net income		60,470			75,425			73,999				92,225
Less: Net income attributable to non-controlling interests		3,773			4,438			3,773				4,438
Net income attributable to Select Medical Holdings Corporation and Select Medical Corporation	$	56,697		$	70,987		$	70,226			$	87,787
Income per common share:
Basic	$	0.35		$	0.46
Diluted	$	0.35		$	0.46

The accompanying notes are an integral part of these consolidated financial statements.

5

Select Medical Holdings Corporation

Consolidated Statement of Changes in Equity and Income

(unaudited)

(in thousands)

						Select Medical Holdings Corporation Stockholders
									Common
				Comprehensive		Common			Stock Par			Capital in			Retained			Non-controlling
	Total			Income		Stock Issued			Value			Excess of Par			Earnings			Interests
Balance at December 31, 2010	$	815,414					154,519		$	155		$	535,628		$	248,097		$	31,534
Net income		75,425		$	75,425											70,987			4,438
Issuance and vesting of restricted stock		1,801					26			(0	)		1,801
Exercise of stock options		169					42			0			169
Stock option expense		897											897
Repurchase of common shares		(31,641	)				(4,650	)		(5	)		(20,200	)		(11,436	)
Distributions to non-controlling interests		(3,507	)																(3,507	)
Other		28																	28
Balance at September 30, 2011	$	858,586					149,937		$	150		$	518,295		$	307,648		$	32,493

Select Medical Corporation
Consolidated Statement of Changes in Equity and Income
(unaudited)
(in thousands)

						Select Medical Corporation Stockholders
								Common
				Comprehensive		Common		Stock Par		Capital in		Retained			Non-controlling
	Total			Income		Stock Issued		Value		Excess of Par		Earnings			Interests
Balance at December 31, 2010	$	1,116,128					0	$	0	$	834,894	$	249,700		$	31,534
Net income		92,225		$	92,225								87,787			4,438
Federal tax benefit of losses contributed by Holdings		9,045									9,045
Additional investment by Holdings		169									169
Net change in dividends payable to Holdings		12,600											12,600
Dividends declared and paid to Holdings		(204,561	)										(204,561	)
Distributions to non-controlling interests		(3,507	)													(3,507	)
Other		28														28
Contribution related to restricted stock awards and stock option issuances by Holdings		2,698									2,698
Balance at September 30, 2011	$	1,024,825					0	$	0	$	846,806	$	145,526		$	32,493

The accompanying notes are an integral part of these consolidated financial statements.

6

Consolidated Statements of Cash Flows

(unaudited)

(in thousands)

	Select Medical Holdings Corporation						Select Medical Corporation
	For the Nine Months Ended September 30,						For the Nine Months Ended September 30,
	2010			2011			2010			2011
Operating activities
Net income	$	60,470		$	75,425		$	73,999		$	92,225
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		51,333			52,766			51,333			52,766
Provision for bad debts		31,449			40,002			31,449			40,002
Loss on early retirement of debt		—			31,018			—			20,385
Loss (gain) from disposal of assets		612			(5,182	)		612			(5,182	)
Non-cash gain from interest rate swaps		(464	)		—			(464	)		—
Non-cash stock compensation expense		1,405			2,698			1,405			2,698
Amortization of debt discount		1,396			1,271			—			412
Changes in operating assets and liabilities, net of effects from acquisition of businesses:
Accounts receivable		(26,668	)		(81,466	)		(26,668	)		(81,466	)
Other current assets		3,571			240			3,571			240
Other assets		494			1,072			88			723
Accounts payable		(3,469	)		14,008			(3,469	)		14,008
Due to third-party payors		(756	)		(1,050	)		(756	)		(1,050	)
Accrued expenses		(13,038	)		(12,566	)		(6,527	)		(3,650	)
Income and deferred taxes		3,930			25,678			11,214			34,723
Net cash provided by operating activities		110,265			143,914			135,787			166,834
Investing activities
Purchases of property and equipment		(38,626	)		(32,094	)		(38,626	)		(32,094	)
Investment in business		—			(13,514	)		—			(13,514	)
Acquisition of businesses, net of cash acquired		(165,802	)		1,921			(165,802	)		1,921
Proceeds from sale of assets		—			7,879			—			7,879
Net cash used in investing activities		(204,428	)		(35,808	)		(204,428	)		(35,808	)
Financing activities
Borrowings on revolving credit facilities		90,000			595,000			90,000			595,000
Payments on revolving credit facilities		(70,000	)		(570,000	)		(70,000	)		(570,000	)
Borrowings on 2011 credit facility term loan, net of discount		—			841,500			—			841,500
Payments on 2011 credit facility term loans		—			(2,125	)		—			(2,125	)
Payments on 2005 credit facility term loans, net of call premium		—			(484,633	)		—			(484,633	)
Repurchase of 10% senior subordinated notes		—			(150,000	)		—			—
Repurchase of 7 5/8% senior subordinated notes, net of tender premium		—			(273,941	)		—			(273,941	)
Borrowings of other debt		5,015			5,496			5,015			5,496
Principal payments on seller and other debt		(6,667	)		(5,846	)		(6,667	)		(5,846	)
Debt issuance costs		—			(18,556	)		—			(18,556	)
Proceeds from (repayment of) bank overdrafts		10,971			(4,174	)		10,971			(4,174	)
Equity investment by Holdings		—			—			125			169
Repurchase of common stock		—			(31,641	)		—			—
Proceeds from issuance of common stock		125			169			—			—
Dividends paid to Holdings		—			—			(25,522	)		(204,561	)
Distributions to non-controlling interests		(3,618	)		(3,507	)		(3,618	)		(3,507	)
Net cash provided by (used in) financing activities		25,826			(102,258	)		304			(125,178	)
Net increase (decrease) in cash and cash equivalents		(68,337	)		5,848			(68,337	)		5,848
Cash and cash equivalents at beginning of period		83,680			4,365			83,680			4,365
Cash and cash equivalents at end of period	$	15,343		$	10,213		$	15,343		$	10,213
Supplemental Cash Flow Information
Cash paid for interest	$	99,897		$	94,632		$	74,381		$	71,719
Cash paid for taxes	$	36,424		$	31,105		$	36,424		$	31,105

The accompanying notes are an integral part of these consolidated financial statements.

7

SELECT MEDICAL HOLDINGS CORPORATION AND SELECT MEDICAL CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

1. Basis of Presentation

Select Medical Corporation (“Select”) was formed in December 1996 and commenced operations during February 1997 upon the completion of its first acquisition. Select Medical Holdings Corporation (“Holdings”) was formed in October 2004 for the purpose of effectuating a leveraged buyout of Select, which was a publicly traded entity. Holdings was originally owned by an investor group that includes Welsh, Carson, Anderson, & Stowe, IX, LP (“Welsh Carson”), Thoma Cressey Bravo (“Thoma Cressey”) and members of the Company’s senior management. On February 24, 2005, Select merged with a subsidiary of Holdings, which resulted in Select becoming a wholly-owned subsidiary of Holdings (the “Merger”). On September 30, 2009, Holdings completed its initial public offering of common stock. Generally accepted accounting principles (“GAAP”) require that any amounts recorded or incurred (such as goodwill and compensation expense) by the parent as a result of the Merger or for the benefit of the subsidiary be “pushed down” and recorded in Select’s consolidated financial statements. Holdings and Select and their subsidiaries are collectively referred to as the “Company.” The consolidated financial statements of Holdings include the accounts of its wholly-owned subsidiary Select. Holdings conducts substantially all of its business through Select and its subsidiaries.

The unaudited condensed consolidated financial statements of the Company as of September 30, 2011 and for the three and nine month periods ended September 30, 2010 and 2011 have been prepared in accordance with GAAP. In the opinion of management, such information contains all adjustments, which are normal and recurring in nature, necessary for a fair statement of the financial position, results of operations and cash flow for such periods. All significant intercompany transactions and balances have been eliminated. The results of operations for the three and nine months ended September 30, 2011 are not necessarily indicative of the results to be expected for the full fiscal year ending December 31, 2011.

Certain information and disclosures normally included in the notes to consolidated financial statements have been condensed or omitted consistent with the rules and regulations of the Securities and Exchange Commission (the “SEC”), although the Company believes the disclosure is adequate to make the information presented not misleading. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December 31, 2010 contained in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 9, 2011.

2. Accounting Policies

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.

8

Recent Accounting Pronouncements

In May 2011, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2011-04, “Fair Value Measurement (Topic 820) — Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs” (“Update 2011-04”). Update 2011-04 generally represents clarification of Topic 820, but also includes instances where a particular principle or requirement for measuring fair value or disclosing information about fair value measurements has changed. Update 2011-04 results in common principles and requirements for measuring fair value and for disclosing information about fair value measurements in accordance with GAAP and International Financial Reporting Standards. Update 2011-04 is effective for interim and annual periods beginning after December 15, 2011 and is to be applied prospectively. Early application is not permitted. The Company does not expect the adoption of Update 2011-04 to have a material impact on its consolidated financial statements.

In June 2011, the FASB issued ASU 2011-05, “Comprehensive Income (Topic 220) — Presentation of Comprehensive Income” (“Update 2011-05”) that improves the comparability, consistency and transparency of financial reporting and increases the prominence of items reported in other comprehensive income by eliminating the option to present components of other comprehensive income as part of the statement of changes in stockholders’ equity. Update 2011-05 requires that all non-owner changes in stockholders’ equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. Under either method, adjustments must be displayed for items that are reclassified from other comprehensive income (“OCI”) to net income, in both net income and OCI. Update 2011-05 does not change the current option for presenting components of OCI gross or net of the effect of income taxes, provided that such tax effects are presented in the statement in which OCI is presented or disclosed in the notes to the financial statements. Additionally, Update 2011-05 does not affect the calculation or reporting of earnings per share. Update 2011-05 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2011 and is to be applied retrospectively, with early adoption permitted. The adoption of Update 2011-05 will cause the Company to change its presentation of other comprehensive income on its consolidated financial statements.

In July 2011, the FASB issued ASU 2011-07, “Health Care Entities (Topic 954): Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts and the Allowance for Doubtful Accounts for Certain Health Care Entities” (“Update 2011-07”). Update 2011-07 requires certain health care entities to change the presentation in their statement of operations by reclassifying the provision for bad debts associated with patient service revenue from an operating expense to a deduction from patient service revenue (net of contractual allowances and discounts). Additionally, those health care entities are required to provide enhanced disclosure about their policies for recognizing revenue and assessing bad debts. The amendments also require disclosures of patient service revenue (net of contractual allowances and discounts) as well as qualitative and quantitative information about changes in the allowance for doubtful accounts. Update 2011-07 is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2011, with early adoption permitted. The Company is in the process of evaluating the effects of Update 2011-07 on its consolidated financial statements.

In September 2011, the FASB issued ASU 2011-08, “Intangibles — Goodwill and Other (Topic 350): Testing Goodwill for Impairment” (“Update 2011-08). Update 2011-08 allows an entity to first assess qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill impairment test. Under Update 2011-08, an entity would not be required to calculate the fair value of a reporting unit unless the entity determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. Update 2011-08 includes a number of events and circumstances for an entity to consider in conducting the qualitative assessment. Update 2011-08 will be effective for goodwill impairment test performed for fiscal years beginning after December 15, 2011. Update 2011-08 does not change the accounting or measurement of impairments. This update will have no effect on the Company’s consolidated financial statements.

9

3. Significant Transactions

On April 1, 2011, the Company entered into a joint venture with Baylor Health Care System. The joint venture consists of a partnership between Baylor Institute for Rehabilitation and Select Physical Therapy Texas, a wholly-owned subsidiary of the Company. The Company contributed several businesses to the joint venture, including its Frisco inpatient rehabilitation facility and certain Texas-based outpatient rehabilitation clinics. A gain of $1.2 million was recognized on this contribution and is included in the general and administrative line item on the consolidated statement of operations for the nine months ended September 30, 2011. Additionally, the Company purchased partnership units and made initial working capital advances to the newly formed partnership utilizing $13.5 million in cash. The Company owns a 49.0% interest in the partnership and is accounting for the investment using the equity method because the Company does not have a controlling influence.

On June 30, 2011, the Company sold a building which it acquired in connection with the acquisition of Regency Hospital Company, L.L.C. for $7.6 million in cash. A gain of $4.2 million was recognized on this sale and is included in the general and administrative line item on the consolidated statement of operations for the nine months ended September 30, 2011.

4. Intangible Assets

The Company’s intangible assets consist of the following:

	As of September 30, 2011
	Gross Carrying		Accumulated
	Amount		Amortization
	(in thousands)
Amortized intangible assets:
Non-compete agreements	$	25,909	$	(25,244	)
Indefinite-lived intangible assets:
Goodwill	$	1,627,509
Trademarks		57,709
Certificates of need		11,914
Accreditations		2,160
Total	$	1,699,292

The Company’s accreditations and trademarks have renewal terms. The costs to renew these intangibles are expensed as incurred. At September 30, 2011, the accreditations and trademarks have a weighted average time until next renewal of approximately 1.5 years and 8.7 years, respectively.

10

Amortization expense for the Company’s intangible assets with finite lives follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2010		2011		2010		2011
	(in thousands)				(in thousands)
Amortization expense	$	869	$	328	$	3,921	$	981

Amortization expense for the Company’s intangible assets primarily relates to the amortization of the value associated with the non-compete agreements entered into in connection with the acquisitions of the outpatient rehabilitation division of HealthSouth Corporation and SemperCare, Inc. The useful lives of the outpatient rehabilitation division of HealthSouth Corporation’s non-compete and the SemperCare, Inc. non-compete are five and seven years, respectively. Amortization expense related to these intangible assets for each of the next five years commencing January 1, 2011 is approximately as follows (in thousands):

2011	$	1,306
2012		340
2013		0
2014		0
2015		0

The changes in the carrying amount of goodwill for the Company’s reportable segments for the nine months ended September 30, 2011 are as follows:

	Specialty			Outpatient
	Hospitals			Rehabilitation			Total
	(in thousands)
Balance as of December 31, 2010	$	1,330,609		$	300,643		$	1,631,252
Goodwill revision (1)		7,114			—			7,114
Purchase price settlement (2)		(3,921	)		—			(3,921	)
Goodwill acquired during the period		2,169			—			2,169
Goodwill allocated to dispositions during the period		(2,750	)		(6,355	)		(9,105	)
Balance as of September 30, 2011	$	1,333,221		$	294,288		$	1,627,509

(1)	During the three months ended March 31, 2011, the Company made a revision to the Regency Hospital Company, L.L.C. purchase price allocation resulting from the finalization of the intangible asset valuations.
(2)	During the three months ended June 30, 2011, the Company completed the post-closing settlement of net working capital with the seller of Regency Hospital Company, L.L.C.

11

5. Restructuring Reserves

In connection with the acquisition of substantially all of the outpatient rehabilitation division of HealthSouth Corporation, the Company recorded an estimated liability of $18.7 million in 2007 for business restructuring which was accounted for as additional purchase price. This reserve primarily included costs associated with workforce reductions and lease termination costs in accordance with the Company’s restructuring plan.

In connection with the acquisition of all the issued and outstanding equity securities of Regency Hospital Company, L.L.C. (“Regency”), an operator of long term acute care hospitals, the Company recorded an estimated liability of $4.3 million in 2010 for business restructuring related to lease termination costs.

The following summarizes the Company’s restructuring activity:

	Lease Termination Costs
	(in thousands)
Balance as of December 31, 2010	$	6,754
Amounts paid in 2011		(1,480	)
Accretion expense		334
Balance as of September 30, 2011	$	5,608

The Company expects to pay out the remaining lease termination costs through 2014 for the acquisition of the outpatient rehabilitation division of HealthSouth Corporation and through 2015 for the lease termination costs related to the Regency acquisition.

6. Indebtedness

The components of long-term debt and notes payable are shown in the following table:

	Holdings				Select
	December 31,		September 30,		December 31,		September 30,
	2010		2011		2010		2011
	(in thousands)
7 5/8% senior subordinated notes	$	611,500	$	345,000	$	611,500	$	345,000
2011 - senior secured credit facilities:
Revolving loan		—		50,000		—		50,000
Term loan (1)		—		839,787		—		839,787
2005 - senior secured credit facilities:
Revolving loan		25,000		—		25,000		—
Term loan B		191,268		—		191,268		—
Term loan B-1		290,576		—		290,576		—
10% senior subordinated notes (2)		139,177		—		—		—
Senior floating rate notes		167,300		167,300		—		—
Other debt		5,948		5,599		5,948		5,599
Total debt		1,430,769		1,407,686		1,124,292		1,240,386
Less: current maturities		149,379		10,268		149,379		10,268
Total long-term debt	$	1,281,390	$	1,397,418	$	974,913	$	1,230,118

(1)	Presented net of unamortized discount of $8.1 million.
(2)	Presented net of unamortized discount of $10.8 million.

12

On June 1, 2011, Select entered into a new senior secured credit agreement (the “Credit Agreement”) that provides for $1.15 billion in senior secured credit facilities (“Senior Secured Credit Facilities”), comprised of an $850.0 million, seven-year term loan facility (“Term Loan”) and a $300.0 million, five-year revolving credit facility (“Revolving Credit Facility”), including a $75.0 million sublimit for the issuance of standby letters of credit and a $25.0 million sublimit for swingline loans.

Select used borrowings under the Senior Secured Credit Facilities to refinance all of its outstanding indebtedness under its existing credit facilities, to repurchase $266.5 million aggregate principal amount of its 7 5/8% senior subordinated notes due 2015 and to repay all of Holdings’ existing 10% senior subordinated notes due 2015. Select recognized a loss on early retirement of debt for the nine months ended September 30, 2011 of $20.4 million related to these transactions. Holdings recognized a loss on early retirement of debt for the nine months ended September 30, 2011 of $31.0 million related to these transactions. Borrowings under the Senior Secured Credit Facilities are guaranteed by Holdings and substantially all of Select’s current domestic subsidiaries and will be guaranteed by Select’s future domestic subsidiaries and secured by substantially all of Select’s existing and future property and assets and by a pledge of Select’s capital stock, the capital stock of Select’s domestic subsidiaries and up to 65% of the capital stock of Select’s foreign subsidiaries, if any.

Borrowings under the Senior Secured Credit Facilities will bear interest at a rate equal to:

• in the case of the Term Loan, Adjusted LIBO plus 3.75%, or Alternative Base Rate plus 2.75%; and

• in the case of the Revolving Credit Facility, Adjusted LIBO plus a percentage ranging from 2.75% to 3.75%, or Alternative Base Rate plus a percentage ranging from 1.75% to 2.75%, in each case based on Select’s leverage ratio.

“Adjusted LIBO” is defined as, with respect to any interest period, the London interbank offered rate for such interest period, adjusted for any applicable statutory reserve requirements; provided that Adjusted LIBO, when used in reference to the Term Loan, will at no time be less than 1.75% per annum.

“Alternative Base Rate” is defined as the highest of (a) the administrative agent’s Prime Rate, (b) the Federal Funds Effective Rate plus 1/2 of 1.00% and (c) the Adjusted LIBO from time to time for an interest period of one month, plus 1.00%.

The applicable margin percentage for revolving loans will decrease from (1) 2.75% to 2.50% for alternate base rate loans and (2) 3.75% to 3.50% for adjusted LIBOR loans upon the delivery of Select’s Form 10-Q to JP Morgan Chase Bank, N.A., as administrative agent to Select’s senior secured credit facility.

The Term Loan will amortize in equal quarterly installments on the last day of each March, June, September and December in aggregate annual amounts equal to $2.1 million commencing in September 2011. The balance of the Term Loan will be payable on June 1, 2018, provided that if on the 90th day prior to the scheduled final maturity date of Select’s 7 5/8% senior subordinated notes due 2015 (the “Tranche B Trigger Date”) more than $60.0 million in aggregate principal amount of Select’s 7 5/8% senior subordinated notes due 2015 are outstanding, the maturity date for the Term Loan will be the Tranche B Trigger Date. Similarly, the Revolving Credit Facility will be payable on June 1, 2016, provided that if on the 90th day prior to the scheduled final maturity date of Select’s 7 5/8% senior subordinated notes due 2015 (the “Revolving Trigger Date”) more than $60.0 million in aggregate principal amount of Select’s 7 5/8% senior subordinated notes due 2015 are outstanding, the maturity date for the Revolving Credit Facility will be the Revolving Trigger Date.

13

Select will be required to prepay borrowings under the Senior Secured Credit Facilities with (1) 100% of the net cash proceeds received from non-ordinary course asset sales or other dispositions, or as a result of a casualty or condemnation, subject to reinvestment provisions and other customary carveouts and the payment of certain indebtedness secured by liens subject to a first lien intercreditor agreement, (2) 100% of the net cash proceeds received from the issuance of debt obligations other than certain permitted debt obligations, and (3) 50% of excess cash flow (as defined in the Credit Agreement) if Select’s leverage ratio is greater than 3.75 to 1.00 and 25% of excess cash flow if Select’s leverage ratio is less than or equal to 3.75 to 1.00 and greater than 3.25 to 1.00, in each case, reduced by the aggregate amount of term loans optionally prepaid during the applicable fiscal year. Select will not be required to prepay borrowings with excess cash flow if Select’s leverage ratio is less than or equal to 3.25 to 1.00.

The Senior Secured Credit Facilities require Select to maintain a leverage ratio (based upon the ratio of indebtedness for money borrowed to consolidated EBITDA, as defined in the Credit Agreement), which is tested quarterly and becomes more restrictive over time, and prohibits Select from making capital expenditures in excess of $125.0 million in any fiscal year (subject to a 50% carry-over provision). Failure to comply with these covenants would result in an event of default under the Senior Secured Credit Facilities and, absent a waiver or an amendment from the lenders, preclude Select from making further borrowings under the Revolving Credit Facility and permit the lenders to accelerate all outstanding borrowings under the Senior Secured Credit Facilities.

The Senior Secured Credit Facilities also contain a number of affirmative and restrictive covenants, including limitations on mergers, consolidations and dissolutions; sales of assets; investments and acquisitions; indebtedness; liens; affiliate transactions; and dividends and restricted payments. The Senior Secured Credit Facilities contain events of default for non-payment of principal and interest when due, cross-default and cross-acceleration provisions and an event of default that would be triggered by a change of control.

Maturities of Long-Term Debt and Notes Payable

Maturities of the Company’s long-term debt for the period from October 1, 2011 through December 31, 2011 and the years after 2011 are approximately as follows and are presented net of the discount on 2011 Senior Secured Credit Facilities’ term loan:

	Holdings		Select
	(in thousands)
2011	$	3,425	$	3,425
2012		8,826		8,826
2013		7,614		7,614
2014		7,613		7,613
2015		519,845		352,545
2016 and beyond		860,363		860,363

7. Fair Value

Financial instruments include cash and cash equivalents, notes payable and long-term debt. The carrying amount of cash and cash equivalents approximates fair value because of the short-term maturity of these instruments.

14

The carrying value of Select’s senior secured credit facilities was $506.8 million and $889.8 million at December 31, 2010 and September 30, 2011, respectively. The fair value of Select’s senior secured credit facilities was $497.7 million and $800.3 million at December 31, 2010 and September 30, 2011, respectively. The fair value of Select’s senior secured credit facilities was based on quoted market prices for this debt in the syndicated loan market.

The carrying value of Select’s 7 5/8% senior subordinated notes was $611.5 million and $345.0 million at December 31, 2010 and September 30, 2011, respectively. The fair value of Select’s 7 5/8% senior subordinated notes was $616.1 million and $300.2 million at December 31, 2010 and September 30, 2011, respectively. The fair value of this publicly traded debt was based on quoted market prices.

The carrying value of Holdings’ senior floating rate notes was $167.3 million at both December 31, 2010 and September 30, 2011. The fair value of Holdings’ senior floating rate notes was $156.0 million and $148.1 million at December 31, 2010 and September 30, 2011, respectively. The fair value of this publicly traded debt was based on quoted market prices.

8. Segment Information

The Company’s reportable segments consist of (i) specialty hospitals and (ii) outpatient rehabilitation. All other represents amounts associated with corporate activities and non-healthcare related services. The outpatient rehabilitation reportable segment has two operating segments: outpatient rehabilitation clinics and contract therapy. These operating segments are aggregated for reporting purposes as they have common economic characteristics and provide a similar service to a similar patient base. The accounting policies of the segments are the same as those described in the summary of significant accounting policies. The Company evaluates performance of the segments based on Adjusted EBITDA. Adjusted EBITDA is defined as net income before interest, income taxes, depreciation and amortization, stock compensation expense, equity in earnings (losses) of unconsolidated subsidiaries, loss on early retirement of debt and other income.

The following tables summarize selected financial data for the Company’s reportable segments for the three and nine months ended September 30, 2010 and 2011. The segment results of Holdings are identical to those of Select with the exception of total assets:

	Three Months Ended September 30, 2010
	Specialty		Outpatient
	Hospitals		Rehabilitation		All Other			Total
	(in thousands)
Net operating revenue	$	419,798	$	168,438	$	14		$	588,250
Adjusted EBITDA		58,282		20,339		(19,195	)		59,426
Total assets:
Select Medical Corporation		2,051,238		487,171		179,551			2,717,960
Select Medical Holdings Corporation		2,051,238		487,171		182,199			2,720,608
Capital expenditures		9,339		2,019		814			12,172

15

	Three Months Ended September 30, 2011
	Specialty		Outpatient
	Hospitals		Rehabilitation		All Other			Total
	(in thousands)
Net operating revenue	$	521,085	$	173,030	$	16		$	694,131
Adjusted EBITDA		81,570		19,435		(14,469	)		86,536
Total assets:
Select Medical Corporation		2,191,493		468,551		89,568			2,749,612
Select Medical Holdings Corporation		2,191,493		468,551		91,066			2,751,110
Capital expenditures		4,957		3,160		281			8,398

	Nine Months Ended September 30, 2010
	Specialty		Outpatient
	Hospitals		Rehabilitation		All Other			Total
	(in thousands)
Net operating revenue	$	1,234,562	$	518,288	$	90		$	1,752,940
Adjusted EBITDA		214,523		66,813		(41,419	)		239,917
Total assets:
Select Medical Corporation		2,051,238		487,171		179,551			2,717,960
Select Medical Holdings Corporation		2,051,238		487,171		182,199			2,720,608
Capital expenditures		29,963		7,187		1,476			38,626

	Nine Months Ended September 30, 2011
	Specialty		Outpatient
	Hospitals		Rehabilitation		All Other			Total
	(in thousands)
Net operating revenue	$	1,561,270	$	524,694	$	102		$	2,086,066
Adjusted EBITDA		273,004		65,308		(46,117	)		292,195
Total assets:
Select Medical Corporation		2,191,493		468,551		89,568			2,749,612
Select Medical Holdings Corporation		2,191,493		468,551		91,066			2,751,110
Capital expenditures		21,574		8,142		2,378			32,094

16

A reconciliation of Adjusted EBITDA to income before income taxes is as follows (in thousands):

	Three Months Ended September 30, 2010
	Specialty			Outpatient
	Hospitals			Rehabilitation			All Other
Adjusted EBITDA	$	58,282		$	20,339		$	(19,195	)
Depreciation and amortization		(11,237	)		(4,953	)		(822	)
Stock compensation expense		—			—			(460	)
										Select Medical
										Holdings			Select Medical
										Corporation			Corporation
Income (loss) from operations	$	47,045		$	15,386		$	(20,477	)	$	41,954		$	41,954
Equity in losses of unconsolidated subsidiaries											(186	)		(186	)
Other income											148			148
Interest expense, net											(27,677	)		(20,821	)
Income before income taxes										$	14,239		$	21,095

	Three Months Ended September 30, 2011
	Specialty			Outpatient
	Hospitals			Rehabilitation			All Other
Adjusted EBITDA	$	81,570		$	19,435		$	(14,469	)
Depreciation and amortization		(12,828	)		(4,003	)		(714	)
Stock compensation expense		—			—			(918	)
										Select Medical
										Holdings			Select Medical
										Corporation			Corporation
Income (loss) from operations	$	68,742		$	15,432		$	(16,101	)	$	68,073		$	68,073
Equity in earnings of unconsolidated subsidiaries											1,653			1,653
Interest expense, net											(24,015	)		(21,407	)
Income before income taxes										$	45,711		$	48,319

17

	Nine Months Ended September 30, 2010
	Specialty			Outpatient
	Hospitals			Rehabilitation			All Other
Adjusted EBITDA	$	214,523		$	66,813		$	(41,419	)
Depreciation and amortization		(33,095	)		(15,752	)		(2,486	)
Stock compensation expense		—			—			(1,405	)
										Select Medical
										Holdings			Select Medical
										Corporation			Corporation
Income (loss) from operations	$	181,428		$	51,061		$	(45,310	)	$	187,179		$	187,179
Equity in losses of unconsolidated subsidiaries											(186	)		(186	)
Other income											464			464
Interest expense, net											(86,998	)		(66,184	)
Income before income taxes										$	100,459		$	121,273

	Nine Months Ended September 30, 2011
	Specialty			Outpatient
	Hospitals			Rehabilitation			All Other
Adjusted EBITDA	$	273,004		$	65,308		$	(46,117	)
Depreciation and amortization		(37,921	)		(12,689	)		(2,156	)
Stock compensation expense		—			—			(2,698	)
										Select Medical
										Holdings			Select Medical
										Corporation			Corporation
Income (loss) from operations	$	235,083		$	52,619		$	(50,971	)	$	236,731		$	236,731
Loss on early retirement of debt											(31,018	)		(20,385	)
Equity in earnings of unconsolidated subsidiaries											1,329			1,329
Interest expense, net											(74,808	)		(59,596	)
Income before income taxes										$	132,234		$	158,079

9. Income per Common Share

The Company applies the two-class method for calculating and presenting income per common share. The two-class method is an earnings allocation formula that determines earnings per share for each class of stock participation rights in undistributed earnings. Effective January 1, 2009 FASB clarified that share based payment awards that have not yet vested meet the definition of a participating security provided the right to receive the dividend is non-forfeitable and non-contingent. Participating securities are defined as securities that participate in dividends with common stock according to a predetermined formula. These participating securities should be included in the computation of basic earnings per share under the two class method. Based upon the clarification made by FASB, the Company concluded that its non-vested restricted stock awards meet the definition of a participating security and should be included in the Company’s computation of basic earnings per share.

18

The following table sets forth for the periods indicated the calculation of net income per share in the Company’s consolidated statement of operations and the differences between basic weighted average shares outstanding and diluted weighted average shares outstanding used to compute basic and diluted earnings per share, respectively:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2010		2011		2010		2011
	(in thousands, except per share amounts)
Numerator:
Net income attributable to Select Medical Holdings Corporation	$	8,009	$	25,596	$	56,697	$	70,987
Less: Earnings allocated to unvested restricted stockholders		25		278		135		763
Net income available to common stockholders	$	7,984	$	25,318	$	56,562	$	70,224
Denominator:
Weighted average shares — basic		159,717		151,470		159,698		152,299
Effect of dilutive securities:
Stock options		238		206		266		223
Weighted average shares — diluted		159,955		151,676		159,964		152,522
Basic income per common share	$	0.05	$	0.17	$	0.35	$	0.46
Diluted income per common share	$	0.05	$	0.17	$	0.35	$	0.46

The following share amounts are shown here for informational and comparative purposes only since their inclusion would be anti-dilutive:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2010		2011		2010		2011
	(in thousands)
Stock options		2,392		2,437		2,383		2,412

10. Commitments and Contingencies

Litigation

To cover claims arising out of the operations of the Company’s specialty hospitals and outpatient rehabilitation facilities, the Company maintains professional malpractice liability insurance and general liability insurance. The Company also maintains umbrella liability insurance covering claims which, due to their nature or amount, are not covered by or not fully covered by the Company’s other insurance policies. These insurance policies also do not generally cover punitive damages and are subject to various deductibles and policy limits. Significant legal actions as well as the cost and possible lack of available insurance could subject the Company to substantial uninsured liabilities.

19

The Company is subject to legal proceedings and claims that arise in the ordinary course of business, which include malpractice claims covered under insurance policies, subject to a self-insured retention of $2.0 million per medical incident for professional liability claims and $2.0 million per occurrence for general liability claims. In the Company’s opinion, the outcome of these actions will not have a material adverse effect on its financial position or results of operations.

Healthcare providers are subject to lawsuits under thequi tamprovisions of the federal False Claims Act.Qui tamlawsuits typically remain under seal (hence, usually unknown to the defendant) for some time while the government decides whether or not to intervene on behalf of a privatequi tamplaintiff (known as a relator) and take the lead in the litigation. These lawsuits can involve significant monetary damages and penalties and award bounties to private plaintiffs who successfully bring the suits. The Company has been a defendant in these cases in the past, and may be named as a defendant in similar cases from time to time in the future.

During the third quarter of 2011, the Company entered into a settlement agreement with the United States government in connection with the previously disclosedqui tamlawsuit filed in Columbus, Ohio against certain subsidiaries of the Company. The lawsuit, filed under seal in September 2007, led to the Company’s receiving, in July 2009, a subpoena from the government seeking various documents concerning the Company’s financial relationships with certain physicians practicing at its long term acute care hospitals in Columbus, Ohio. Under the terms of the settlement, the Company agreed to pay $7.5 million to the government and enter into a 5-year corporate integrity agreement covering its long term acute care hospitals. The Company also agreed to pay certain legal fees of thequi tamrelator’s counsel. In the settlement agreement, the Company admitted no liability or wrongdoing. During the second quarter of 2011, the Company recorded a pre-tax charge of $7.5 million to establish a settlement reserve in connection with the matter. The settlement amounts and counsel fees were paid in full during the third quarter of 2011, and the Company does not expect to incur any additional material charges in connection with this matter.

Construction Commitments

At September 30, 2011, the Company had outstanding commitments under construction contracts related to new construction, improvements and renovations at the Company’s long term acute care properties and inpatient rehabilitation facilities totaling approximately $2.7 million.

11. Common Stock Repurchase Program

On August 3, 2011, the Company’s board of directors authorized an increase of $50.0 million in the capacity of its common stock repurchase program, from $100.0 million to $150.0 million. The other terms of the program remain unchanged. The program will now remain in effect until March 31, 2013, unless extended by the board of directors. Stock repurchases under this program may be made in the open market or through privately negotiated transactions, and at times and in such amounts as the Company deems appropriate.

20

12. Financial Information for Subsidiary Guarantors and Non-Guarantor Subsidiaries under Select’s 7 5/8% Senior Subordinated Notes

Select’s 7 5/8% senior subordinated notes are fully and unconditionally guaranteed, except for customary limitations, on a senior subordinated basis by all of Select’s wholly-owned subsidiaries (the “Subsidiary Guarantors”). Certain of Select’s subsidiaries did not guarantee the 7 5/8% senior subordinated notes (the “Non-Guarantor Subsidiaries”).

Select conducts a significant portion of its business through its subsidiaries. Presented below is condensed consolidating financial information for Select, the Subsidiary Guarantors and the Non-Guarantor Subsidiaries at December 31, 2010 and September 30, 2011 and for the three and nine months ended September 30, 2010 and 2011.

The equity method has been used by Select with respect to investments in subsidiaries. The equity method has been used by Subsidiary Guarantors with respect to investments in Non-Guarantor Subsidiaries. Separate financial statements for Subsidiary Guarantors are not presented.

The following table sets forth the Non-Guarantor Subsidiaries at September 30, 2011:

Caritas Rehab Services, LLC
Elizabethtown Physical Therapy, P.S.C.
Great Lakes Specialty Hospital — Hackley, LLC
Great Lakes Specialty Hospital — Oak, LLC
Jeffersontown Physical Therapy, LLC
Kentucky Orthopedic Rehabilitation, LLC
Kessler Core PT, OT and Speech Therapy at New York, LLC
Louisville Physical Therapy, P.S.C.
Metropolitan West Physical Therapy and Sports Medicine Services, Inc.
MKJ Physical Therapy, Inc.
New York Physician Services, P.C.
North Andover Physical Therapy, P.C
Penn State Hershey Rehabilitation, LLC
Philadelphia Occupational Health, P.C.
Rehabilitation Physician Services, P.C.
Regency Hospital of Fort Worth, L.L.P.
Select LifeCare Western Michigan, LLC
Select Physical Therapy of Las Vegas Limited Partnership
Select Specialty — Downriver, LLC
Select Specialty Hospital — Akron, LLC
Select Specialty Hospital — Evansville, LLC
Select Specialty Hospital — Central Pennsylvania, L.P.
Select Specialty Hospital — Houston, L.P.
Select Specialty Hospital — Gulf Coast, Inc.
SSM Select Rehab St. Louis, LLC
Therex, P.C.
TJ Corporation I, LLC
U.S. Regional Occupational Health II, P.C.
U.S. Regional Occupational Health II of New Jersey, P.C.

21

Select Medical Corporation

Condensed Consolidating Balance Sheet

September 30, 2011

(unaudited)

	Select Medical
	Corporation
	(Parent Company		Subsidiary			Non-Guarantor
	Only)		Guarantors			Subsidiaries			Eliminations			Consolidated
	(in thousands)
Assets
Current Assets:
Cash and cash equivalents	$	8,968	$	580		$	665		$	—		$	10,213
Accounts receivable, net		—		352,525			42,464			—			394,989
Current deferred tax asset		10,455		6,025			3,354			—			19,834
Prepaid income taxes		10,340		—			—			—			10,340
Other current assets		5,015		19,885			3,206			—			28,106
Total Current Assets		34,778		379,015			49,689			—			463,482
Property and equipment, net		7,176		444,451			54,267			—			505,894
Investment in affiliates		2,727,699		77,954			—			(2,805,653	)(a) (b)		—
Goodwill		—		1,627,509			—			—			1,627,509
Other identifiable intangibles		—		72,448			—			—			72,448
Assets held for sale		11,342		—			—			—			11,342
Other assets		30,599		37,423			915			—			68,937
Total Assets	$	2,811,594	$	2,638,800		$	104,871		$	(2,805,653	)	$	2,749,612
Liabilities and Equity
Current Liabilities:
Bank overdrafts	$	14,618	$	—		$	—		$	—		$	14,618
Current portion of long-term debt and notes payable		9,584		384			300			—			10,268
Accounts payable		7,649		70,007			11,286			—			88,942
Intercompany accounts		954,939		(865,649	)		(89,290	)		—			—
Accrued payroll		412		70,288			217			—			70,917
Accrued vacation		3,608		38,715			5,920			—			48,243
Accrued interest		4,562		8			583			—			5,153
Accrued restructuring		—		5,608			—			—			5,608
Accrued other		42,332		56,347			6,374			—			105,053
Due to third party payors		—		14,935			(10,686	)		—			4,249
Total Current Liabilities		1,037,704		(609,357	)		(75,296	)		—			353,051
Long-term debt, net of current portion		723,410		445,070			61,638			—			1,230,118
Non-current deferred tax liability		1,321		58,651			8,427			—			68,399
Other non-current liabilities		56,827		16,392			—			—			73,219
Total Liabilities		1,819,262		(89,244	)		(5,231	)		—			1,724,787
Stockholder’s Equity:
Common stock		0		—			—			—			0
Capital in excess of par		846,806		—			—			—			846,806
Retained earnings		145,526		604,446			21,637			(626,083	)(b)		145,526
Subsidiary investment		—		2,123,598			55,972			(2,179,570	)(a)		—
Total Select Medical Corporation Stockholder’s Equity		992,332		2,728,044			77,609			(2,805,653	)		992,332
Non-controlling interest		—		—			32,493			—			32,493
Total Equity		992,332		2,728,044			110,102			(2,805,653	)		1,024,825
Total Liabilities and Equity	$	2,811,594	$	2,638,800		$	104,871		$	(2,805,653	)	$	2,749,612

(a)	Elimination of investments in consolidated subsidiaries.
(b)	Elimination of investments in consolidated subsidiaries’ earnings.

22

Select Medical Corporation

Condensed Consolidating Statement of Operations

For the Three Months Ended September 30, 2011

(unaudited)

	Select Medical						Non-
	Corporation (Parent			Subsidiary			Guarantor
	Company Only)			Guarantors			Subsidiaries			Eliminations			Consolidated
	(in thousands)
Net operating revenues	$	16		$	603,737		$	90,378		$	—		$	694,131
Costs and expenses:
Cost of services		430			502,576			78,823			—			581,829
General and administrative		14,804			171			—			—			14,975
Bad debt expense		—			10,219			1,490			—			11,709
Depreciation and amortization		641			14,484			2,420			—			17,545
Total costs and expenses		15,875			527,450			82,733			—			626,058
Income (loss) from operations		(15,859	)		76,287			7,645			—			68,073
Other income and expense:
Intercompany interest and royalty fees		(659	)		655			4			—			—
Intercompany management fees		18,698			(14,320	)		(4,378	)		—			—
Equity in earnings of unconsolidated subsidiaries		—			1,633			20			—			1,653
Interest income		36			16			67			—			119
Interest expense		(12,556	)		(7,874	)		(1,096	)		—			(21,526	)
Income (loss) from operations before income taxes		(10,340	)		56,397			2,262			—			48,319
Income tax expense (benefit)		(1,502	)		21,215			530			—			20,243
Equity in earnings of subsidiaries		36,129			1,761			—			(37,890	)(a)		—
Net income		27,291			36,943			1,732			(37,890	)		28,076
Less: Net income attributable to non-controlling interests		—			—			785			—			785
Net income attributable to Select Medical Corporation	$	27,291		$	36,943		$	947		$	(37,890	)	$	27,291

(a) Elimination of equity in earnings of subsidiaries.

23

Select Medical Corporation
Condensed Consolidating Statement of Operations
For the Nine Months Ended September 30, 2011
(unaudited)

	Select Medical						Non-
	Corporation (Parent			Subsidiary			Guarantor
	Company Only)			Guarantors			Subsidiaries			Eliminations			Consolidated
	(in thousands)
Net operating revenues	$	102		$	1,809,552		$	276,412		$	—		$	2,086,066
Costs and expenses:
Cost of services		1,262			1,476,857			230,792			—			1,708,911
General and administrative		47,298			358			—			—			47,656
Bad debt expense		—			35,128			4,874			—			40,002
Depreciation and amortization		1,941			43,939			6,886			—			52,766
Total costs and expenses		50,501			1,556,282			242,552			—			1,849,335
Income (loss) from operations		(50,399	)		253,270			33,860			—			236,731
Other income and expense:
Intercompany interest and royalty fees		(2,654	)		2,635			19			—			—
Intercompany management fees		86,561			(73,451	)		(13,110	)		—			—
Loss on early retirement of debt		(20,385	)		—			—			—			(20,385	)
Equity in earnings of unconsolidated subsidiaries		—			1,285			44			—			1,329
Interest income		101			117			68			—			286
Interest expense		(28,932	)		(27,193	)		(3,757	)		—			(59,882	)
Income (loss) from operations before income taxes		(15,708	)		156,663			17,124			—			158,079
Income tax expense (benefit)		(214	)		65,259			809			—			65,854
Equity in earnings of subsidiaries		103,281			12,342			—			(115,623	)(a)		—
Net income		87,787			103,746			16,315			(115,623	)		92,225
Less: Net income attributable to non-controlling interests		—			—			4,438			—			4,438
Net income attributable to Select Medical Corporation	$	87,787		$	103,746		$	11,877		$	(115,623	)	$	87,787

(a) Elimination of equity in earnings of subsidiaries.

24

Select Medical Corporation
Condensed Consolidating Statement of Cash Flows
For the Nine Months Ended September 30, 2011
(unaudited)

	Select Medical						Non-
	Corporation (Parent			Subsidiary			Guarantor
	Company Only)			Guarantors			Subsidiaries			Eliminations			Consolidated
	(in thousands)
Operating activities
Net income	$	87,787		$	103,746		$	16,315		$	(115,623	)(a)	$	92,225
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		1,941			43,939			6,886			—			52,766
Provision for bad debts		—			35,128			4,874			—			40,002
Loss on early retirement of debt		20,385			—			—			—			20,385
Loss (gain) from disposal of assets		13			(5,233	)		38			—			(5,182	)
Non-cash stock compensation expense		2,698			—			—			—			2,698
Amortization of debt discount		412			—			—			—			412
Changes in operating assets and liabilities, net of effects from acquisition of businesses:
Equity in earnings of subsidiaries		(103,281	)		(12,342	)		—			115,623	(a)		—
Intercompany		60,188			(49,269	)		(10,919	)		—			—
Accounts receivable		—			(73,437	)		(8,029	)		—			(81,466	)
Other current assets		(455	)		412			283			—			240
Other assets		(8,306	)		8,826			203			—			723
Accounts payable		1,622			10,102			2,284			—			14,008
Due to third-party payors		—			2,710			(3,760	)		—			(1,050	)
Accrued expenses		(4,455	)		701			104			—			(3,650	)
Income and deferred taxes		34,723			—			—			—			34,723
Net cash provided by operating activities		93,272			65,283			8,279			—			166,834
Investing activities
Purchases of property and equipment		(2,384	)		(26,342	)		(3,368	)		—			(32,094	)
Investment in business		—			(13,514	)		—			—			(13,514	)
Acquisition of businesses, net of cash acquired		—			1,921			—			—			1,921
Proceeds from sale of assets		—			7,879			—			—			7,879
Net cash used in investing activities		(2,384	)		(30,056	)		(3,368	)		—			(35,808	)
Financing activities
Borrowings on revolving credit facility		595,000			—			—			—			595,000
Payments on revolving credit facility		(570,000	)		—			—			—			(570,000	)
Borrowings on 2011 credit facility term loan		841,500			—			—			—			841,500
Payments on 2011 credit facility term loans, net of discount		(2,125	)		—			—			—			(2,125	)
Payments on 2005 credit facility term loans, net of call premium		(484,633	)		—			—			—			(484,633	)
Repurchase of 7 5/8% senior subordinated notes, net of tender premium		(273,941	)		—			—			—			(273,941	)
Borrowings of other debt		5,496			—			—			—			5,496
Principal payments on seller and other debt		(4,326	)		(650	)		(870	)		—			(5,846	)
Debt issuance costs		(18,556	)		—			—			—			(18,556	)
Repayments of bank overdrafts		(4,174	)		—			—			—			(4,174	)
Equity investment by Holdings		169			—			—			—			169
Dividends paid to Holdings		(204,561	)		—			—			—			(204,561	)
Intercompany debt reallocation		38,082			(37,564	)		(518	)		—			—
Distributions to non-controlling interests		—			—			(3,507	)		—			(3,507	)
Net cash used in financing activities		(82,069	)		(38,214	)		(4,895	)		—			(125,178	)
Net increase (decrease) in cash and cash equivalents		8,819			(2,987	)		16			—			5,848
Cash and cash equivalents at beginning of period		149			3,567			649			—			4,365
Cash and cash equivalents at end of period	$	8,968		$	580		$	665		$	—		$	10,213

(a) Elimination of equity in earnings of consolidated subsidiaries.

25

Select Medical Corporation
Condensed Consolidating Balance Sheet
December 31, 2010
(unaudited)

	Select Medical
	Corporation (Parent		Subsidiary			Non-Guarantor
	Company Only)		Guarantors			Subsidiaries			Eliminations			Consolidated
	(in thousands)
Assets
Current Assets:
Cash and cash equivalents	$	149	$	3,567		$	649		$	—		$	4,365
Accounts receivable, net		—		314,123			39,309			—			353,432
Current deferred tax asset		8,007		19,226			3,421			—			30,654
Prepaid income taxes		12,699		—			—			—			12,699
Other current assets		4,560		20,127			3,489			—			28,176
Total Current Assets		25,415		357,043			46,868			—			429,326
Property and equipment, net		6,806		467,554			57,740			—			532,100
Investment in affiliates		2,667,767		81,839			—			(2,749,606	)(a) (b)		—
Goodwill		—		1,631,252			—			—			1,631,252
Other identifiable intangibles		—		80,119			—			—			80,119
Assets held for sale		11,342		—			—			—			11,342
Other assets		22,293		12,022			1,118			—			35,433
Total Assets	$	2,733,623	$	2,629,829		$	105,726		$	(2,749,606	)	$	2,719,572
Liabilities and Equity
Current Liabilities:
Bank overdrafts	$	18,792	$	—		$	—		$	—		$	18,792
Current portion of long-term debt and notes payable		147,609		758			1,012			—			149,379
Accounts payable		6,027		59,164			9,002			—			74,193
Intercompany accounts		925,741		(832,683	)		(93,058	)		—			—
Accrued payroll		967		62,539			254			—			63,760
Accrued vacation		3,255		37,948			5,385			—			46,588
Accrued interest		21,198		388			—			—			21,586
Accrued restructuring		—		6,754			—			—			6,754
Accrued other		29,948		79,157			7,351			—			116,456
Due to third party payors		—		12,225			(6,926	)		—			5,299
Total Current Liabilities		1,153,537		(573,750	)		(76,980	)		—			502,807
Long-term debt, net of current portion		429,743		482,858			62,312			—			974,913
Non-current deferred tax liability		2,266		48,976			7,832			—			59,074
Other non-current liabilities		63,483		3,167			—			—			66,650
Total Liabilities		1,649,029		(38,749	)		(6,836	)		—			1,603,444
Stockholder’s Equity:
Common stock		0		—			—			—			0
Capital in excess of par		834,894		—			—			—			834,894
Retained earnings		249,700		500,700			24,587			(525,287	)(b)		249,700
Subsidiary investment		—		2,167,878			56,441			(2,224,319	)(a)		—
Total Select Medical Corporation Stockholder’s Equity		1,084,594		2,668,578			81,028			(2,749,606	)		1,084,594
Non-controlling interest		—		—			31,534			—			31,534
Total Equity		1,084,594		2,668,578			112,562			(2,749,606	)		1,116,128
Total Liabilities and Equity	$	2,733,623	$	2,629,829		$	105,726		$	(2,749,606	)	$	2,719,572

(a)	Elimination of investments in subsidiaries.
(b)	Elimination of investments in subsidiaries’ retained earnings.

26

Select Medical Corporation
Condensed Consolidating Statement of Operations
For the Quarter Ended September 30, 2010
(unaudited)

	Select Medical						Non-
	Corporation (Parent			Subsidiary			Guarantor
	Company Only)			Guarantors			Subsidiaries			Eliminations			Consolidated
	(in thousands)
Net operating revenues	$	14		$	507,589		$	80,647		$	—		$	588,250
Costs and expenses:
Cost of services		440			427,761			70,538			—			498,739
General and administrative		17,031			2,197			—			—			19,228
Bad debt expense		—			9,661			1,656			—			11,317
Depreciation and amortization		662			14,249			2,101			—			17,012
Total costs and expenses		18,133			453,868			74,295			—			546,296
Income (loss) from operations		(18,119	)		53,721			6,352			—			41,954
Other income and expense:
Intercompany interest and royalty fees		(888	)		877			11			—			—
Intercompany management fees		22,773			(18,937	)		(3,836	)		—			—
Equity in losses of unconsolidated subsidiaries		—			(186	)		—			—			(186	)
Other income		148			—			—			—			148
Interest expense		(11,330	)		(8,462	)		(1,029	)		—			(20,821	)
Income (loss) from operations before income taxes		(7,416	)		27,013			1,498			—			21,095
Income tax expense		366			7,600			8			—			7,974
Equity in earnings of subsidiaries		20,247			965			—			(21,212	)(a)		—
Net income		12,465			20,378			1,490			(21,212	)		13,121
Less: Net income attributable to non-controlling interests		—			—			656			—			656
Net income attributable to Select Medical Corporation	$	12,465		$	20,378		$	834		$	(21,212	)	$	12,465

(a) Elimination of equity in net income from consolidated subsidiaries.

27

Select Medical Corporation
Condensed Consolidating Statement of Operations
For the Nine Months Ended September 30, 2010
(unaudited)

	Select Medical						Non-
	Corporation (Parent			Subsidiary			Guarantor
	Company Only)			Guarantors			Subsidiaries			Eliminations			Consolidated
	(in thousands)
Net operating revenues	$	90		$	1,509,246		$	243,604		$	—		$	1,752,940
Costs and expenses:
Cost of services		1,094			1,236,392			203,674			—			1,441,160
General and administrative		39,590			2,229			—			—			41,819
Bad debt expense		—			26,402			5,047			—			31,449
Depreciation and amortization		2,160			42,787			6,386			—			51,333
Total costs and expenses		42,844			1,307,810			215,107			—			1,565,761
Income (loss) from operations		(42,754	)		201,436			28,497			—			187,179
Other income and expense:
Intercompany interest and royalty fees		(2,849	)		2,829			20			—			—
Intercompany management fees		68,002			(56,706	)		(11,296	)		—			—
Equity in losses of unconsolidated subsidiaries		—			(186	)		—			—			(186	)
Other income		464			—			—			—			464
Interest expense		(37,430	)		(25,466	)		(3,288	)		—			(66,184	)
Income (loss) from operations before income taxes		(14,567	)		121,907			13,933			—			121,273
Income tax expense (benefit)		1,856			46,159			(741	)		—			47,274
Equity in earnings of subsidiaries		86,649			10,831			—			(97,480	)(a)		—
Net income		70,226			86,579			14,674			(97,480	)		73,999
Less: Net income attributable to non-controlling interests		—			—			3,773			—			3,773
Net income attributable to Select Medical Corporation	$	70,226		$	86,579		$	10,901		$	(97,480	)	$	70,226

(a) Elimination of equity in net income from consolidated subsidiaries.

28

Select Medical Corporation
Condensed Consolidating Statement of Cash Flows
For the Nine Months Ended September 30, 2010
(unaudited)

	Select Medical						Non-
	Corporation (Parent			Subsidiary			Guarantor
	Company Only)			Guarantors			Subsidiaries			Eliminations			Consolidated
	(in thousands)
Operating activities
Net income	$	70,226		$	86,579		$	14,674		$	(97,480	)(a)	$	73,999
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization		2,160			42,787			6,386			—			51,333
Provision for bad debts		—			26,402			5,047			—			31,449
Loss from disposal of assets		127			352			133			—			612
Non-cash gain from interest rate swaps		(464	)		—			—			—			(464	)
Non-cash stock compensation expense		1,405			—			—			—			1,405
Changes in operating assets and liabilities, net of effects from acquisition of businesses:
Equity in earnings of subsidiaries		(86,649	)		(10,831	)		—			97,480	(a)		—
Intercompany		(54,741	)		62,368			(7,627	)		—			—
Accounts receivable		—			3,119			(29,787	)		—			(26,668	)
Other current assets		2,593			(1,959	)		2,937			—			3,571
Other assets		228			1,621			(1,761	)		—			88
Accounts payable		4,579			(8,228	)		180			—			(3,469	)
Due to third-party payors		—			(10,170	)		9,414			—			(756	)
Accrued expenses		(30,729	)		22,401			1,801			—			(6,527	)
Income and deferred taxes		11,214			—			—			—			11,214
Net cash provided by (used in) operating activities		(80,051	)		214,441			1,397			—			135,787
Investing activities
Purchases of property and equipment		(1,475	)		(30,107	)		(7,044	)		—			(38,626	)
Acquisition of businesses, net of cash acquired		—			(165,802	)		—			—			(165,802	)
Net cash used in investing activities		(1,475	)		(195,909	)		(7,044	)		—			(204,428	)
Financing activities
Borrowings on revolving credit facility		90,000			—			—			—			90,000
Payments on revolving credit facility		(70,000	)		—			—			—			(70,000	)
Borrowings of other debt		5,015			—			—			—			5,015
Principal payments on seller and other debt		(5,181	)		(1,428	)		(58	)		—			(6,667	)
Dividends paid to Holdings		(25,522	)		—			—			—			(25,522	)
Equity investment by Holdings		125			—			—			—			125
Proceeds from bank overdrafts		10,971			—			—			—			10,971
Intercompany debt reallocation		3,363			(12,788	)		9,425			—			—
Distributions to non-controlling interests		—			—			(3,618	)		—			(3,618	)
Net cash provided by (used in) financing activities		8,771			(14,216	)		5,749			—			304
Net increase (decrease) in cash and cash equivalents		(72,755	)		4,316			102			—			(68,337	)
Cash and cash equivalents at beginning of period		80,940			2,298			442			—			83,680
Cash and cash equivalents at end of period	$	8,185		$	6,614		$	544		$	—		$	15,343

(a) Elimination of equity in earnings of consolidated subsidiaries.

29

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read this discussion together with our unaudited consolidated financial statements and accompanying notes.

Forward Looking Statements

This report contains forward-looking statements within the meaning of the federal securities laws. Statements that are not historical facts, including statements about our beliefs and expectations, are forward-looking statements. Forward-looking statements include statements preceded by, followed by or that include the words “may,” “could,” “would,” “should,” ‘believe,” “expect,” “anticipate,” “plan,” “target,” “ estimate,” “project,” “intend,” and similar expressions. These statements include, among others, statements regarding our expected business outlook, anticipated financial and operating results, our business strategy and means to implement our strategy, our objectives, the amount and timing of capital expenditures, the likelihood of our success in expanding our business, financing plans, budgets, working capital needs and sources of liquidity.

Forward-looking statements are only predictions and are not guarantees of performances. These statements are based on our management’s beliefs and assumptions, which in turn are based on currently available information. Important assumptions relating to the forward-looking statements include, among others, assumptions regarding our services, the expansion of our services, competitive conditions and general economic conditions. These assumptions could prove inaccurate. Forward-looking statements also involve known and unknown risks and uncertainties, which could cause actual results to differ materially from those contained in any forward-looking statement. Many of these factors are beyond our ability to control or predict. Such factors include, but are not limited to, the following:

• additional changes in government reimbursement for our services, including changes that will result from the expiration of the moratorium for long term acute care hospitals established by the Medicare, Medicaid and SCHIP Extension Act of 2007, the American Recovery and Reinvestment Act, and the Patient Protection and Affordable Care Act may result in a reduction in net operating revenues, an increase in costs and a reduction in profitability;

• the failure of our specialty hospitals to maintain their Medicare certifications may cause our net operating revenues and profitability to decline;

• the failure of our facilities operated as “hospitals within hospitals” to qualify as hospitals separate from their host hospitals may cause our net operating revenues and profitability to decline;

• a government investigation or assertion that we have violated applicable regulations may result in sanctions or reputational harm and increased costs;

• acquisitions or joint ventures may prove difficult or unsuccessful, use significant resources or expose us to unforeseen liabilities;

• private third-party payors for our services may undertake future cost containment initiatives that limit our future net operating revenues and profitability;

• the failure to maintain established relationships with the physicians in the areas we serve could reduce our net operating revenues and profitability;

• shortages in qualified nurses or therapists could increase our operating costs significantly;

• competition may limit our ability to grow and result in a decrease in our net operating revenues and profitability;

• the loss of key members of our management team could significantly disrupt our operations;

• the effect of claims asserted against us could subject us to substantial uninsured liabilities and in the future we may not be able to obtain insurance at a reasonable price; and

• other factors discussed from time to time in our filings with the Securities and Exchange Commission (the “SEC”), including factors discussed under the heading “Risk Factors” for the year ended December 31, 2010 contained in our annual report on Form 10-K filed with the Securities and Exchange Commission on March 9, 2011.

30

Except as required by applicable law, including the securities laws of the United States and the rules and regulations of the SEC, we are under no obligation to publicly update or revise any forward-looking statements, whether as a result of any new information, future events or otherwise. You should not place undue reliance on our forward-looking statements. Although we believe that the expectations reflected in forward-looking statements are reasonable, we cannot guarantee future results or performance.

Investors should also be aware that while we do, from time to time, communicate with securities analysts, it is against our policy to disclose to security analysts any material non-public information or other confidential commercial information. Accordingly, stockholders should not assume that we agree with any statement or report issued by any analyst irrespective of the content of the statement or report. Thus, to the extent that reports issued by securities analysts contain any projections, forecasts or opinions, such reports are not the responsibility of the Company.

Overview

We believe that we are one of the largest operators of both specialty hospitals and outpatient rehabilitation clinics in the United States based on number of facilities. As of September 30, 2011, we operated 110 long term acute care hospitals and nine inpatient rehabilitation facilities in 28 states, and 952 outpatient rehabilitation clinics in 34 states and the District of Columbia. We also provide medical rehabilitation services on a contracted basis to nursing homes, hospitals, assisted living and senior care centers, schools and work sites. We began operations in 1997 under the leadership of our current management team.

We manage our Company through two business segments, our specialty hospital segment and our outpatient rehabilitation segment. We had net operating revenues of $2,086.1 million for the nine months ended September 30, 2011. Of this total, we earned approximately 75% of our net operating revenues from our specialty hospitals and approximately 25% from our outpatient rehabilitation business, compared to 70% and 30% respectively in the comparable period in 2010. The increase in the relative portion of our net operating revenues generated from our specialty hospitals resulted from the hospitals added through our Regency Hospital Company, L.L.C. (“Regency”) acquisition on September 1, 2010. Our specialty hospital segment consists of hospitals designed to serve the needs of long term stay acute patients and hospitals designed to serve patients that require intensive inpatient medical rehabilitation care. Patients are typically admitted to our long term acute care hospitals from general acute care hospitals. These patients have specialized needs, and serious and often complex medical conditions such as respiratory failure, neuromuscular disorders, traumatic brain and spinal cord injuries, strokes, non-healing wounds, cardiac disorders, renal disorders and cancer. Our outpatient rehabilitation segment consists of clinics and contract services that provide physical, occupational and speech rehabilitation services. Our outpatient rehabilitation patients are typically diagnosed with musculoskeletal impairments that restrict their ability to perform normal activities of daily living.

31

Significant 2011 Events

Refinancing

On June 1, 2011, Select Medical Corporation (“Select”) entered into a new senior secured credit agreement that provides for $1.15 billion in senior secured credit facilities, comprised of an $850.0 million, seven-year term loan facility and a $300.0 million five-year revolving credit facility of which $125.0 million was drawn at closing. The refinancing also included the repurchase of $266.5 million aggregate principal amount of Select’s 7 5/8% senior subordinated notes due 2015 and the repurchase of all $150.0 million principal amount of Holdings’ 10.0% senior subordinated notes.

At September 30, 2011, Select had outstanding an $847.9 million term loan (at aggregate principal value) and a $50.0 million balance on the revolving portion of its senior secured credit facilities and $345.0 million in principal amount of 7 5/8% senior subordinated notes due 2015. Holdings also had $167.3 million in principal amount outstanding of its senior floating rate notes due 2015.

Significant Transactions

On April 1, 2011, we entered into a joint venture with Baylor Health Care System (“Baylor JV”). The joint venture consists of a partnership between Baylor Institute for Rehabilitation and Select Physical Therapy Texas, a wholly-owned subsidiary of Select. We contributed several businesses to the joint venture, including our Frisco inpatient rehabilitation facility and certain of our Texas-based outpatient rehabilitation clinics. A gain of $1.2 million was recognized on this contribution during the second quarter of 2011 and is included in the general and administrative line item on the consolidated statement of operations for the nine months ended September 30, 2011. Additionally, on April 1, 2011 we purchased partnership units and made working capital advances to the newly formed partnership utilizing $13.5 million in cash. We own a 49.0% interest in the partnership and account for the investment using the equity method because we do not have a controlling interest.

On June 30, 2011, we sold a building which we acquired in connection with the acquisition of Regency for $7.6 million in cash. A gain of $4.2 million was recognized on this sale and is included in the general and administrative line item on the consolidated statement of operations for the nine months ended September 30, 2011.

Litigation

During the third quarter of 2011, we entered into a settlement agreement with the United States government in connection with the previously disclosedqui tamlawsuit filed in Columbus, Ohio against certain of our subsidiaries. The lawsuit, filed under seal in September 2007, led to the Company’s receiving, in July 2009, a subpoena from the government seeking various documents concerning our financial relationships with certain physicians practicing at our long term acute care hospitals in Columbus, Ohio. Under the terms of the settlement, we agreed to pay $7.5 million to the government and entered into a 5-year corporate integrity agreement covering our long term acute care hospitals. We also agreed to pay certain legal fees of thequi tamrelator’s counsel. In the settlement agreement, we admitted no liability or wrongdoing. During the second quarter of 2011, we recorded a pre-tax charge of $7.5 million to establish a settlement reserve in connection with the matter. The settlement amounts and counsel fees were paid in full during the third quarter 2011, and we do not expect to incur any additional material charges in connection with this matter.

32

Stock Repurchase Program

On August 3, 2011, our board of directors authorized an increase of $50.0 million in the capacity of our common stock repurchase program, from $100.0 million to $150.0 million. The other terms of the program remain unchanged. The program will now remain in effect until March 31, 2013, unless extended by the board of directors. Stock repurchases under this program may be made in the open market or through privately negotiated transactions, and at times and in such amounts as we deem appropriate. Through September 30, 2011, we have repurchased 11,555,447 shares for an aggregate cost, including transaction fees, of $75.8 million.

Summary Financial Results

Third Quarter Ended September 30, 2011

For the three months ended September 30, 2011, our net operating revenues increased 18.0% to $694.1 million compared to $588.3 million for the three months ended September 30, 2010. This increase in net operating revenues resulted principally from a 24.1% increase in our specialty hospital net operating revenue. The increase in our specialty hospital net operating revenue is primarily due to the Regency hospitals acquired on September 1, 2010. We had income from operations for the three months ended September 30, 2011 of $68.1 million compared to $42.0 million for the three months ended September 30, 2010. The increase in income from operations resulted from the addition of the Regency hospitals acquired on September 1, 2010, improved operating performance at our other specialty hospitals and lower general and administrative costs. Holdings’ interest expense for the three months ended September 30, 2011 was $24.1 million compared to $27.7 million for the three months ended September 30, 2010. Select’s interest expense for the three months ended September 30, 2011 was $21.5 million compared to $20.8 million for the three months ended September 30, 2010. The decrease in interest expense for Holdings was attributable to a reduction in our average interest rate that resulted from lower interest rates on portions of the debt we refinanced on June 1, 2011. Higher interest expense was incurred by Select because a portion of Holdings debt for which Select was not previously obligated was refinanced at Select through indebtedness incurred under the new senior secured credit facility on June 1, 2011.

For the nine months ended September 30, 2011, our net operating revenues increased 19.0% to $2,086.1 million compared to $1,752.9 million for the nine months ended September 30, 2010. This increase in net operating revenues resulted principally from a 26.5% increase in our specialty hospital net operating revenue. The increase in our specialty hospital net operating revenue is primarily due to the Regency hospitals acquired on September 1, 2010. We had income from operations for the nine months ended September 30, 2011 of $236.7 million compared to $187.2 million for the nine months ended September 30, 2010. The increase in income from operations resulted from the addition of the Regency hospitals acquired on September 1, 2010 and improved operating performance at our other specialty hospitals, offset in part by an increase in general and administrative costs. Holdings’ interest expense for the nine months ended September 30, 2011 was $75.1 million compared to $87.0 million for the nine months ended September 30, 2010. Select’s interest expense for the nine months ended September 30, 2011 was $59.9 million compared to $66.2 million for the nine months ended September 30, 2010. The decrease in interest expense for both Holdings and Select was primarily attributable to a reduction in our average interest rate that resulted from the expiration of interest rate swaps during 2010 and lower interest rates on portions of the debt we refinanced on June 1, 2011.

Cash flow from operations provided $143.9 million of cash for the nine months ended September 30, 2011 for Holdings and provided $166.8 million of cash for the nine months ended September 30, 2011 for Select. The difference between Holdings and Select primarily relates to interest payments on Holdings’ 10% senior subordinated notes and senior floating rate notes.

33

Regulatory Changes

In the past few years, there have been significant regulatory changes that have affected our net operating revenues and, in some cases, caused us to change our operating models and strategies. The following is a discussion of recent regulatory changes that have affected our results of operations for the three and nine months ended September 30, 2011 or may have an affect on our future results of operations. Our Annual Report on Form 10-K for the year ended December 31, 2010 filed with the Securities and Exchange Commission (“SEC”) on March 9, 2011 contains a more detailed discussion of the regulations that affect our business in Part I — Business — Government Regulations, and the information below should be read in connection with that more detailed discussion.

Health Reform Legislation

Federal agencies, including the Centers for Medicare & Medicaid Services (“CMS”), continue to implement provisions of the Patient Protection and Affordable Care Act (“PPACA”). The PPACA expands access to health insurance through subsidies, coverage mandates and other insurance market reforms. In addition, PPACA makes dramatic changes to the Medicare and Medicaid programs by adopting numerous initiatives addressing, among other things, reductions in healthcare spending, patient safety incentives and protections against fraud and abuse of federal healthcare programs. The PPACA adopts significant changes to the Medicare program that are particularly relevant to long term acute care hospitals (“LTCHs”), inpatient rehabilitation facilities (“IRFs”) and outpatient rehabilitation services. As part of health reform legislation, President Obama also signed the “Health Care and Education Affordability Reconciliation Act of 2010,” which made some limited but important changes to the PPACA.

We have included in our Annual Report on Form 10-K for the year ended December 31, 2010 a detailed discussion of the PPACA provisions that affect our business, as well as regulatory initiatives adopted by CMS in response to particular provisions of the PPACA.

Medicare Payment of Long Term Acute Care Hospitals during Fiscal Year 2011

On August 16, 2010, CMS published the policies and payment rates for long term care hospital prospective payment system (“LTCH-PPS”) for fiscal year 2011 (affecting discharges and cost reporting periods beginning on or after October 1, 2010 through September 30, 2011). The standard federal rate for fiscal year 2011 is $39,600, which is a decrease from the fiscal year 2010 federal rate of $39,897 in effect from October 1, 2009 to March 31, 2010 and $39,795 in effect from April 1, 2010 to September 30, 2010. The final rule established a fixed-loss amount for high cost outlier cases for fiscal year 2011 of $18,785, which is higher than the fiscal year 2010 fixed-loss amount of $18,425 in effect from October 1, 2009 to March 31, 2010 and $18,615 in effect from April 1, 2010 to September 31, 2010. The final rule included revisions to the relative weights for the Medicare severity long term care diagnostic related groups for fiscal year 2011.

Medicare Payment of Long Term Acute Care Hospitals during Fiscal Year 2012

On August 18, 2011, CMS published the policies and payment rates for LTCH-PPS for fiscal year 2012 (affecting discharges and cost reporting periods beginning on or after October 1, 2011 through September 30, 2012). The standard federal rate for fiscal year 2012 is $40,222, an increase from the fiscal year 2011 federal rate of $39,600. The final rule establishes a fixed loss amount for high cost outlier cases for fiscal year 2012 of $17,931, which is a decrease from the fixed loss amount in the 2011 fiscal year of $18,785. The final rule included revisions to the relative weights for the Medicare severity long term care diagnostic related groups for fiscal year 2012.

34

The labor-related share of the LTCH-PPS standard federal rate is adjusted annually to account for geographic differences in area wage levels by applying the applicable LTCH-PPS wage index. CMS adopted a decrease in the labor-related share from 75.271% to 70.199% under the LTCH-PPS for fiscal year 2012. In addition, CMS applied an area wage level budget neutrality factor to the standard federal rate to make annual changes to the area wage level adjustment budget neutral. Previously, there was no statutory or regulatory requirement that these adjustments to the area wage level be made in a budget neutral manner. The final rule creates a regulatory requirement that any adjustments or updates to the area wage level adjustment be made in a budget neutral manner such that estimated aggregate LTCH-PPS payments are not affected.

An LTCH must have an average inpatient length of stay for Medicare patients (including both Medicare covered and non-covered days) of greater than 25 days. In the preamble to the final rule for fiscal year 2012, CMS clarified its policy on the calculation of the average length of stay by specifying that all data on all Medicare inpatient days, including Medicare Advantage days, must be included in the average length of stay calculation effective for cost reporting periods beginning on or after January 1, 2012. CMS now has the ability to capture Medicare Advantage days through the required submission of “information only” bills for Medicare Advantage patients.

Medicare Payment of Inpatient Rehabilitation Facilities during Fiscal Year 2011

On July 22, 2010, CMS published an update to the payment rates for inpatient rehabilitation facility prospective payment system (“IRF-PPS”) for fiscal year 2011 (affecting discharges and cost reporting periods beginning on or after October 1, 2010 through September 30, 2011). The standard payment conversion factor for discharges during fiscal year 2011 is $13,860 which is an increase from $13,661 in effect from October 1, 2009 to March 31, 2010 and $13,627 in effect from April 1, 2010 to September 30, 2010. CMS also increased the outlier threshold amount for fiscal year 2011 to $11,410 from $10,721 in fiscal year 2010. The final rule included updates to the Case-Mix-Group (“CMG”) relative weights and average length of stay values for fiscal year 2011.

Medicare Payment of Inpatient Rehabilitation Facilities during Fiscal Year 2012

On August 5, 2011, CMS published the policies and payment rates for IRF-PPS for fiscal year 2012 (affecting discharges and cost reporting periods beginning on or after October 1, 2011 and through September 30, 2012). The standard payment conversion factor for fiscal year 2012 is $14,076 which is an increase from $13,860 applicable during fiscal year 2011. CMS decreased the outlier threshold amount for fiscal year 2012 to $10,660 from $11,410 for fiscal year 2011. The final rule includes updates to the CMG relative weights and average length of stay values for fiscal year 2012. In a notice published September 26, 2011, CMS revised its calculation of the outlier threshold amount for fiscal year 2012 which changed the amount from $10,660 to $10,713 and made corrections to the CMG relative weights.

The IRF-PPS provides a low-income patient adjustment to account for the cost differences associated with treatment of low-income patients. Similarly, the IRF-PPS provides a teaching adjustment to account for the higher indirect operating costs experienced by hospitals that participate in graduate medical education programs. The teaching adjustment is based on the number of full-time equivalent interns and residents training in the IRF and the IRF’s average daily census. In the proposed rule for fiscal year 2012, CMS proposed updating the low-income patient and teaching status adjustment factors. However, after receiving public comments on its proposal, CMS decided to maintain the same low-income patient and teaching status adjustment factors that applied in fiscal year 2011. CMS indicated that it would continue to review its policies on these adjustment factors.

35

Medicare Payment of Outpatient Rehabilitation Services

Medicare Physician Fee Schedule Sustainable Growth Rate Update

The Medicare program reimburses outpatient rehabilitation providers based on the Medicare Physician Fee Schedule. The Medicare Physician Fee Schedule rates are automatically updated annually based on a formula, called the sustainable growth rate (“SGR”) formula, contained in legislation. The SGR formula has resulted in automatic reductions in rates in every year since 2002; however, for each year through 2011 CMS or Congress has taken action to prevent the SGR formula reductions. The Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010 provided a 2.2% increase to Medicare Physician Fee Schedule payment rates, retroactive from June 1, 2010 through November 30, 2010, suspending a 21.3% reduction that briefly became effective on June 1, 2010. The Medicare and Medicaid Extenders Act of 2010 (“MMEA”) prevented a 25.5% reduction in the Medicare Physician Fee Schedule payment rates as a result of the SGR formula that would have taken effect on January 1, 2011. The MMEA extends the current Medicare Physician Fee Schedule payment rates through December 31, 2011.

On November 1, 2011 CMS released the 2012 Medicare Physician Fee Schedule final rule and noted that due to the SGR formula, the physician fee schedule update for calendar year 2012 is projected to be a 27.4% reduction unless Congress again takes legislative action to prevent the SGR formula reductions from going into effect. Over the last several years, Congress has taken legislative action to avert these cuts prior to their effective date. If the 27.4% cut is averted by Congress, the projected impact of other changes in the rule on outpatient physical therapy service payments in aggregate would be a 4.0% increase in 2012, primarily due to the continued phase in of new practice expense survey data derived from the Physician Practice Information Survey (“PPIS”). In 2013, when the use of the PPIS data is fully phased in, the impact would be a 6.0% increase for outpatient physical therapy payments.

On October 6, 2011, the Medicare Payment Advisory Commission (MedPAC) voted to recommend that Congress repeal and replace the statutory SGR formula. The MedPAC proposal — which would require congressional approval — would freeze current Medicare Physician Fee Schedule rates for primary care services for ten years, while other services would be subject to annual payment reductions of 5.9% for three years, followed by a freeze. MedPAC offered a list of options for Congress to consider if it decides to offset SGR repeal costs (estimated at about $200 billion over ten years) within the Medicare program. For the year ended December 31, 2010, we received approximately 10% of our outpatient rehabilitation net operating revenues from Medicare.

Therapy Caps

Beginning on January 1, 1999, the Balanced Budget Act of 1997 subjected certain outpatient therapy providers reimbursed under the Medicare Physician Fee Schedule to annual limits for therapy expenses. Effective January 1, 2012, the annual limit on outpatient therapy services is $1,880 for combined physical and speech language pathology services and $1,880 for occupational therapy services. The per beneficiary caps were $1,870 for calendar year 2011 and $1,860 for calendar year 2010. In the Deficit Reduction Act of 2005, Congress implemented an exceptions process to the annual limit for therapy expenses. Under this process, a Medicare enrollee (or person acting on behalf of the Medicare enrollee) is able to request an exception from the therapy caps if the provision of therapy services was deemed to be medically necessary. Therapy cap exceptions have been available automatically for certain conditions and on a case-by-case basis upon submission of documentation of medical necessity. The MMEA extended the exceptions process for outpatient therapy caps

36

through December 31, 2011. Unless Congress extends the exceptions process, the therapy caps will apply to all outpatient therapy services beginning on January 1, 2012, except those services furnished and billed by outpatient hospital departments. The 2011 final Medicare Physician Fee Schedule rule indicated that CMS is evaluating alternative payment methodologies that may provide appropriate payment for medically necessary and effective therapy services furnished to Medicare beneficiaries based on patient needs rather than the current therapy caps. As in past years, congressional action will be necessary to extend the exceptions process after December 31, 2011.

Multiple Procedure Payment Reduction

CMS adopted a multiple procedure payment reduction for therapy services in the final update to the Medicare Physician Fee Schedule for calendar year 2011. Under the policy, the Medicare program pays 100% of the practice expense component of the therapy procedure or unit of service with the highest Relative Value Unit (“RVU”), and then reduces the payment for the practice expense component by 20% in office and other non-institutional settings and 25% in institutional settings for the second and subsequent therapy procedures or units of service furnished during the same day for the same patient, regardless of whether those therapy services are furnished in separate sessions. This multiple procedure payment reduction policy (“MPPR”) was effective January 1, 2011 and applies to all outpatient therapy services paid under Medicare Part B. Furthermore, the multiple procedure payment reduction policy applies across all therapy disciplines — occupational therapy, physical therapy and speech-language pathology. Our outpatient rehabilitation therapy services are primarily offered in institutional settings and, as such, will be subject to the applicable 25% payment reduction in the practice expense component for the second and subsequent therapy services furnished by us to the same patient on the same day. In the final 2012 Medicare Physician Fee Schedule rule, CMS indicated that over the next year it will continue to review whether specific Current Procedural Terminology (“CPT”) codes billed under the fee schedule are overvalued or undervalued, including certain specific CPT codes used by physical therapists.

Medicare Quality Reporting Program for LTCHs and IRFs

The PPACA requires that CMS establish new quality data reporting programs for LTCHs and IRFs by fiscal year 2014. CMS has adopted a quality data reporting program requiring LTCHs to submit data from three quality measures in order to receive the full payment update in fiscal year 2014, including measures related to (1) catheter-associated urinary tract infections, (2) central line catheter-associated blood stream infection, and (3) pressure ulcers that are new or have worsened. CMS adopted a quality data reporting program requiring IRFs to submit data from two quality measures in order to receive the full payment update in fiscal year 2014, including measures related to (1) catheter-associated urinary tract infections and (2) pressure ulcers that are new or have worsened. Under the PPACA and CMS regulations, if an LTCH or IRF fails to report on the selected quality measures, it will see its reimbursement reduced by 2.0% of the annual market basket update. The reduction can result in payment rates less than the prior year. However, the reduction will not carry over into the subsequent fiscal years.

37

Facility Licensure, Certification and Accreditation

Our specialty hospitals and outpatient rehabilitation clinics are subject to extensive and changing federal, state and local regulations and private accreditation standards. Hospitals are required to comply with state hospital standards setting requirements related to patient rights, composition and responsibilities of the hospital governing body, medical staff, quality improvement, infection control, nursing services, food and nutrition, medical records, drug distribution, diagnostic and treatment services, surgical services, emergency services and social work. Our specialty hospitals are also required to meet conditions of participation under Medicare programs in order to qualify to receive reimbursement under these programs. In addition, all of our specialty hospitals are currently accredited by The Joint Commission, previously known as The Joint Commission on Accreditation of Healthcare Organizations, by voluntarily complying with a specific set of accreditation standards.

Our specialty hospitals and outpatient rehabilitation clinics are subject to inspections, surveys and other reviews by governmental and private regulatory authorities, not only at scheduled intervals but also in response to complaints from patients and others. While our specialty hospitals and outpatient rehabilitation clinics intend to comply with existing licensing, Medicare certification requirements and accreditation standards, there can be no assurance that regulatory authorities will determine that all applicable requirements are fully met at any given time. A determination by an applicable regulatory authority that a facility is not in compliance with these requirements could lead to the imposition of requirements that the facility takes corrective action, assessment of fines and penalties or loss of licensure, Medicare certification or accreditation. These consequences could have a material adverse effect on the Company.

On September 15, 2011, the United States Government Accountability Office (“GAO”) issued a report concerning the oversight of LTCHs. The GAO examined the extent to which CMS (1) collects data about LTCHs’ quality of care and (2) oversees LTCH survey activities. GAO identified several potential areas where the data may assist CMS in more effectively overseeing survey activities at LTCHs, such as how effectively state survey agencies triage and conduct complaint validation surveys. The GAO report recommends that CMS strengthen its oversight of LTCHs by improving available data on quality of care and by improving oversight of LTCH survey activities. According to the GAO, the Department of Health and Human Services concurred with the GAO’s recommendations.

38

Operating Statistics

The following tables set forth operating statistics for our specialty hospitals and our outpatient rehabilitation clinics for each of the periods presented. The data in the tables reflect the changes in the number of specialty hospitals and outpatient rehabilitation clinics we operate that resulted from acquisitions, start-up activities, closures and sales. The operating statistics reflect data for the period of time these operations were managed by us.

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2010			2011			2010			2011
Specialty hospital data(1):
Number of hospitals owned — start of period		94			115			94			116
Number of hospitals acquired		23			—			23			1
Number of hospitals closed/sold		(2	)		—			(2	)		(2	)
Number of hospitals owned — end of period		115			115			115			115
Number of hospitals managed — end of period		2			4			2			4
Total number of hospitals (all) — end of period		117			119			117			119
Available licensed beds		5,117			5,135			5,117			5,135
Admissions		11,305			13,599			33,022			40,965
Patient days		275,387			333,322			808,133			994,179
Average length of stay (days)		24			25			24			24
Net revenue per patient day(2)	$	1,478		$	1,474		$	1,481		$	1,498
Occupancy rate		65	%		71	%		68	%		71	%
Percent patient days — Medicare		64	%		65	%		64	%		65	%
Outpatient rehabilitation data:
Number of clinics owned — start of period		880			849			883			875
Number of clinics acquired		1			—			1			—
Number of clinic start-ups		7			7			17			22
Number of clinics closed/sold		(9	)		(9	)		(22	)		(50	)
Number of clinics owned — end of period		879			847			879			847
Number of clinics managed — end of period		71			105			71			105
Total number of clinics (all) — end of period		950			952			950			952
Number of visits		1,144,096			1,099,342			3,442,266			3,381,896
Net revenue per visit (3)	$	101		$	103		$	101		$	103

(1)	Specialty hospitals consist of long term acute care hospitals and inpatient rehabilitation facilities.
(2)	Net revenue per patient day is calculated by dividing specialty hospital direct patient service revenues by the total number of patient days.
(3)	Net revenue per visit is calculated by dividing outpatient rehabilitation clinic revenue by the total number of visits. For purposes of this computation, outpatient rehabilitation clinic revenue does not include managed clinics or contract services revenue.

39

Results of Operations

The following table outlines, for the periods indicated, selected operating data as a percentage of net operating revenues:

	Select Medical Holdings
	Corporation						Select Medical Corporation
	Three Months						Three Months
	Ended						Ended
	September 30,						September 30,
	2010			2011			2010			2011
Net operating revenues		100.0	%		100.0	%		100.0	%		100.0	%
Cost of services(1)		84.8			83.8			84.8			83.8
General and administrative		3.3			2.2			3.3			2.2
Bad debt expense		1.9			1.7			1.9			1.7
Depreciation and amortization		2.9			2.5			2.9			2.5
Income from operations		7.1			9.8			7.1			9.8
Equity in earnings (losses) of unconsolidated subsidiaries		(0.0	)		0.2			(0.0	)		0.2
Other income		0.0			—			0.0			—
Interest expense, net		(4.7	)		(3.4	)		(3.5	)		(3.1	)
Income before income taxes		2.4			6.6			3.6			6.9
Income tax expense		0.9			2.8			1.4			2.9
Net income		1.5			3.8			2.2			4.0
Net income attributable to non-controlling interest		0.1			0.1			0.1			0.1
Net income attributable to Holdings and Select		1.4	%		3.7	%		2.1	%		3.9	%

	Select Medical Holdings
	Corporation						Select Medical Corporation
	Nine Months						Nine Months
	Ended						Ended
	September 30,						September 30,
	2010			2011			2010			2011
Net operating revenues		100.0	%		100.0	%		100.0	%		100.0	%
Cost of services(1)		82.2			81.9			82.2			81.9
General and administrative		2.4			2.3			2.4			2.3
Bad debt expense		1.8			1.9			1.8			1.9
Depreciation and amortization		2.9			2.5			2.9			2.5
Income from operations		10.7			11.4			10.7			11.4
Loss on early retirement of debt		—			(1.5	)		—			(0.9	)
Equity in earnings (losses) of unconsolidated subsidiaries		(0.0	)		0.0			(0.0	)		0.0
Other income		0.0			—			0.0			—
Interest expense, net		(5.0	)		(3.6	)		(3.8	)		(2.9	)
Income before income taxes		5.7			6.3			6.9			7.6
Income tax expense		2.3			2.7			2.7			3.2
Net income		3.4			3.6			4.2			4.4
Net income attributable to non-controlling interest		0.2			0.2			0.2			0.2
Net income attributable to Holdings and Select		3.2	%		3.4	%		4.0	%		4.2	%

40

The following tables summarize selected financial data by business segment, for the periods indicated:

	Select Medical Holdings Corporation									Select Medical Corporation
	Three Months Ended September 30,									Three Months Ended September 30,
							%									%
	2010			2011			Change			2010			2011			Change
	(in thousands)
Net operating revenues:
Specialty hospitals	$	419,798		$	521,085			24.1	%	$	419,798		$	521,085			24.1	%
Outpatient rehabilitation		168,438			173,030			2.7			168,438			173,030			2.7
Other(3)		14			16			14.3			14			16			14.3
Total company	$	588,250		$	694,131			18.0	%	$	588,250		$	694,131			18.0	%
Income (loss) from operations:
Specialty hospitals	$	47,045		$	68,742			46.1	%	$	47,045		$	68,742			46.1	%
Outpatient rehabilitation		15,386			15,432			0.3			15,386			15,432			0.3
Other(3)		(20,477	)		(16,101	)		21.4			(20,477	)		(16,101	)		21.4
Total company	$	41,954		$	68,073			62.3	%	$	41,954		$	68,073			62.3	%
Adjusted EBITDA:(2)
Specialty hospitals	$	58,282		$	81,570			40.0	%	$	58,282		$	81,570			40.0	%
Outpatient rehabilitation		20,339			19,435			(4.4	)		20,339			19,435			(4.4	)
Other(3)		(19,195	)		(14,469	)		24.6			(19,195	)		(14,469	)		24.6
Adjusted EBITDA margins:(2)
Specialty hospitals		13.9	%		15.7	%					13.9	%		15.7	%
Outpatient rehabilitation		12.1			11.2						12.1			11.2
Other(3)		N/M			N/M						N/M			N/M
Total assets:
Specialty hospitals	$	2,051,238		$	2,191,493					$	2,051,238		$	2,191,493
Outpatient rehabilitation		487,171			468,551						487,171			468,551
Other(3)		182,199			91,066						179,551			89,568
Total company	$	2,720,608		$	2,751,110					$	2,717,960		$	2,749,612
Purchases of property and equipment, net:
Specialty hospitals	$	9,339		$	4,957					$	9,339		$	4,957
Outpatient rehabilitation		2,019			3,160						2,019			3,160
Other(3)		814			281						814			281
Total company	$	12,172		$	8,398					$	12,172		$	8,398

41

	Select Medical Holdings Corporation									Select Medical Corporation
	Nine Months Ended September 30,									Nine Months Ended September 30,
							%									%
	2010			2011			Change			2010			2011			Change
	(in thousands)
Net operating revenues:
Specialty hospitals	$	1,234,562		$	1,561,270			26.5	%	$	1,234,562		$	1,561,270			26.5	%
Outpatient rehabilitation		518,288			524,694			1.2			518,288			524,694			1.2
Other(3)		90			102			13.3			90			102			13.3
Total company	$	1,752,940		$	2,086,066			19.0	%	$	1,752,940		$	2,086,066			19.0	%
Income (loss) from operations:
Specialty hospitals	$	181,428		$	235,083			29.6	%	$	181,428		$	235,083			29.6	%
Outpatient rehabilitation		51,061			52,619			3.1			51,061			52,619			3.1
Other(3)		(45,310	)		(50,971	)		(12.5	)		(45,310	)		(50,971	)		(12.5	)
Total company	$	187,179		$	236,731			26.5	%	$	187,179		$	236,731			26.5	%
Adjusted EBITDA:(2)
Specialty hospitals	$	214,523		$	273,004			27.3	%	$	214,523		$	273,004			27.3	%
Outpatient rehabilitation		66,813			65,308			(2.3	)		66,813			65,308			(2.3	)
Other(3)		(41,419	)		(46,117	)		(11.3	)		(41,419	)		(46,117	)		(11.3	)
Adjusted EBITDA margins:(2)
Specialty hospitals		17.4	%		17.5	%					17.4	%		17.5	%
Outpatient rehabilitation		12.9			12.4						12.9			12.4
Other(3)		N/M			N/M						N/M			N/M
Total assets:
Specialty hospitals	$	2,051,238		$	2,191,493					$	2,051,238		$	2,191,493
Outpatient rehabilitation		487,171			468,551						487,171			468,551
Other(3)		182,199			91,066						179,551			89,568
Total company	$	2,720,608		$	2,751,110					$	2,717,960		$	2,749,612
Purchases of property and equipment, net:
Specialty hospitals	$	29,963		$	21,574					$	29,963		$	21,574
Outpatient rehabilitation		7,187			8,142						7,187			8,142
Other(3)		1,476			2,378						1,476			2,378
Total company	$	38,626		$	32,094					$	38,626		$	32,094

42

N/M — Not Meaningful.

(1)	Cost of services includes salaries, wages and benefits, operating supplies, lease and rent expense and other operating costs.
(2)	We define Adjusted EBITDA as net income before interest, income taxes, depreciation and amortization, stock compensation expense, equity in earnings (losses) of unconsolidated subsidiaries, loss on early retirement of debt and other income. We believe that the presentation of Adjusted EBITDA is important to investors because Adjusted EBITDA is commonly used as an analytical indicator of performance by investors within the healthcare industry. Adjusted EBITDA is used by management to evaluate financial performance and determine resource allocation for each of our operating units. Adjusted EBITDA is not a measure of financial performance under GAAP. Items excluded from Adjusted EBITDA are significant components in understanding and assessing financial performance. Adjusted EBITDA should not be considered in isolation or as an alternative to, or substitute for, net income, cash flows generated by operations, investing or financing activities, or other financial statement data presented in the consolidated financial statements as indicators of financial performance or liquidity. Because Adjusted EBITDA is not a measurement determined in accordance with GAAP and is thus susceptible to varying calculations, Adjusted EBITDA as presented may not be comparable to other similarly titled measures of other companies. See Note 8 to our interim unaudited consolidated financial statements for the period ended September 30, 2011 for a reconciliation of net income to Adjusted EBITDA as utilized by us in reporting our segment performance.
(3)	Other includes our general and administrative services and non-healthcare services.

Three Months Ended September 30, 2011 Compared to Three Months Ended September 30, 2010

In the following discussion, we address the results of operations of Select and Holdings. With the exception of incremental interest expense and income taxes, the results of operations of Holdings are identical to those of Select. Therefore, discussion related to net operating revenue, operating expenses, Adjusted EBITDA, income from operations and non-controlling interest is identical for Holdings and Select.

Net Operating Revenues

Our net operating revenues increased by 18.0% to $694.1 million for the three months ended September 30, 2011 compared to $588.3 million for the three months ended September 30, 2010.

Specialty Hospitals.Our specialty hospital net operating revenues increased by 24.1% to $521.1 million for the three months ended September 30, 2011 compared to $419.8 million for the three months ended September 30, 2010. The Regency hospitals acquired on September 1, 2010 contributed $84.1 million of net revenue, or $61.3 million of the increased net operating revenues. The remaining increase resulted primarily from an increase in patient volumes in our other specialty hospitals. Our patient days increased 21.0% from the three months ended September 30, 2010 to 333,322 days for the three months ended September 30, 2011, which was primarily related to the addition of the Regency hospitals. The Regency hospitals contributed a net increase in patient days of 37,354 days. Excluding the effect of the Regency hospitals, patient days would have increased 8.0% compared to the same quarter, prior year primarily as a result of increased Medicare patient volumes. The occupancy percentage increased to 71% for the three months ended September 30, 2011 from 65% for the three months ended September 30, 2010. Our average net revenue per patient day was $1,474 for the three months ended September 30, 2011 compared to $1,478 for the three months ended September 30, 2010. The decrease in our net revenue per patient day resulted from a decline in our average non-Medicare net revenue per patient day which resulted from a lower non-Medicare per patient day rate realized at the rehabilitation hospital we acquired through a hospital exchange in January 2011.

43

Outpatient Rehabilitation.Our outpatient rehabilitation net operating revenues for the segment increased 2.7% to $173.0 million for the three months ended September 30, 2011 compared to $168.4 million for the three months ended September 30, 2010. The net operating revenues generated by our outpatient rehabilitation clinics grew approximately 2.4% compared to the three months ended September 30, 2010. The increase was principally related to revenues we are generating from services provided to the Baylor JV. The number of patient visits in our owned outpatient rehabilitation clinics decreased 3.9% for the three months ended September 30, 2011 to 1,099,342 visits compared to 1,144,096 visits for the three months ended September 30, 2010. The decrease in visits, which also slowed our revenue growth, resulted from the 18 clinics in the Dallas-Fort Worth metroplex that were contributed to the Baylor JV, which is accounted for as an unconsolidated joint venture, and the adverse effect hurricanes Irene and Lee had on our clinics in the Mid-Atlantic and Northeast regions. Net revenue per visit in our clinics increased 2.0% to $103 for the three months ended September 30, 2011, compared to $101 for the three months ended September 30, 2010. Our contract services business experienced an increase in net operating revenues of approximately 3.9% compared to the three months ended September 30, 2010, which was the result of growth from existing locations where we provide therapy services and new locations that have been added in 2011.

Operating Expenses

Our operating expenses include our cost of services, general and administrative expense and bad debt expense. Our operating expenses increased by $79.2 million to $608.5 million for the three months ended September 30, 2011 compared to $529.3 million for the three months ended September 30, 2010. As a percentage of our net operating revenues, our operating expenses were 87.7% for the three months ended September 30, 2011 compared to 90.0% for the three months ended September 30, 2010. Our cost of services, a major component of which is labor expense, were $581.8 million for the three months ended September 30, 2011 compared to $498.7 million for the three months ended September 30, 2010. The principal cause of this increase resulted from the addition of the Regency hospitals. Additionally, our facility rent expense, which is a component of cost of services, was $29.5 million for the three months ended September 30, 2011 compared to $29.8 million for the three months ended September 30, 2010. General and administrative expenses were 2.2% of net operating revenue or $15.0 million for three months ended September 30, 2011, compared to 3.3% of net operating revenue or $19.2 million for three months ended September 30, 2010. Our general and administrative costs in the three month period ended September 30, 2010 included $2.1 million of costs related to the transition of management functions and closing of the Regency corporate office and a $4.8 million charge due to an increase in employee healthcare costs. These increases in 2010 were partially offset by a reduction of $1.8 million in incentive compensation for executive officers in 2010. Our bad debt expense as a percentage of net operating revenues was 1.7% for the three months ended September 30, 2011 compared to 1.9% for the three months ended September 30, 2010. The decline principally occurred in our outpatient rehabilitation segment and was due to improved collection activity.

Adjusted EBITDA

Specialty Hospitals.Our specialty hospital Adjusted EBITDA increased by 40.0% to $81.6 million for the three months ended September 30, 2011 compared to $58.3 million for the three months ended September 30, 2010. Adjusted EBITDA margins for the segment increased to 15.7% for the three months ended September 30, 2011 from 13.9% for the three months ended September 30, 2010. For the three months ended September 30, 2011, the Regency hospitals acquired on September 1, 2010 contributed $12.7 million of the increase in specialty hospital Adjusted EBITDA. Excluding the effect of the Regency hospitals in both periods, the Adjusted EBITDA margin would have been 16.0% and 14.9% for the three months ended September 30, 2011 and 2010, respectively. In addition to the Adjusted EBITDA contribution from the Regency hospitals, the increase in the Adjusted EBITDA for the remainder of our specialty hospitals was primarily the result of the increase in patient volumes described above under “Net Operating Revenues — Specialty Hospitals” and lower operating costs. During the three months ended September 30, 2010 we incurred an unanticipated $4.0 million charge due to an abnormal increase in our workers compensation program costs.

44

Outpatient Rehabilitation. Our outpatient rehabilitation Adjusted EBITDA for the segment decreased by 4.4% to $19.4 million for the three months ended September 30, 2011 compared to $20.3 million for the three months ended September 30, 2010. Our outpatient rehabilitation Adjusted EBITDA margins for the segment decreased to 11.2% for the three months ended September 30, 2011 from 12.1% for the three months ended September 30, 2010. The Adjusted EBITDA in our outpatient rehabilitation clinics increased by $1.1 million for the three months ended September 30, 2011 compared to the three months ended September 30, 2010. Additionally, our Adjusted EBITDA margins for our outpatient rehabilitation clinics grew to 12.5% for the three months ended September 30, 2011 from 12.0% for the three months ended September 30, 2010. The increase in our Adjusted EBITDA and Adjusted EBITDA margin in our rehabilitation clinics was primarily due to an increase in our net revenue per visit and lower bad debt expense. We experienced a decline in the Adjusted EBITDA and Adjusted EBITDA margin of our contract services business that resulted from higher labor costs for the treatment models required by RUGS IV/MDS 3.0 rules that became effective on October 1, 2010 and higher labor costs associated with the recently added contract therapy locations.

Other. The Adjusted EBITDA loss was $14.5 million for the three months ended September 30, 2011 compared to an Adjusted EBITDA loss of $19.2 million for the three months ended September 30, 2010 and is primarily related to our general and administrative expenses as described above under “Operating Expenses.”

Income from Operations

For the three months ended September 30, 2011 we had income from operations of $68.1 million compared to $42.0 million for the three months ended September 30, 2010. The increase in income from operations resulted primarily from the Regency hospitals acquired on September 1, 2010, which contributed $11.5 million of income from operations for the quarter, and improved operating performance at our other specialty hospitals, and lower general and administrative costs.

Interest Expense

Select Medical Corporation.Interest expense was $21.5 million for the three months ended September 30, 2011 compared to $20.8 million for the three months ended September 30, 2010. The increase in interest expense for Select resulted from the repayment of $150.0 million of Holdings debt, for which Select was not previously obligated, which was refinanced at Select through indebtedness incurred under the new senior secured credit facility on June 1, 2011.

Select Medical Holdings Corporation.Interest expense was $24.1 million for the three months ended September 30, 2011 compared to $27.7 million for the three months ended September 30, 2010. The decrease in interest expense resulted primarily from lower interest rates on the portions of the debt that were refinanced on June 1, 2011.

45

Income Taxes

Select Medical Corporation.We recorded income tax expense of $20.2 million for the three months ended September 30, 2011. The expense represented an effective tax rate of 41.9%. We recorded income tax expense of $8.0 million for the three months ended September 30, 2010. The expense represented an effective tax rate of 37.8%. Select Medical Corporation is part of the consolidated federal tax return for Select Medical Holdings Corporation. We allocate income taxes between Select and Holdings for purposes of financial statement presentation. Because Holdings is a passive investment company incorporated in Delaware, it does not incur any state income tax expense or benefit on its specific income or loss and, as such, receives a tax allocation equal to the federal statutory rate of 35% on its specific income or loss. Based upon the relative size of Holdings’ income or loss, this can cause the effective tax rate for Select to differ from the effective tax rate for the consolidated company. The analysis in the following paragraph discusses the change in our consolidated tax rate.

Select Medical Holdings Corporation.We recorded income tax expense of $19.3 million for the three months ended September 30, 2011. The expense represented an effective tax rate of 42.3%. We recorded income tax expense of $5.6 million for the three months ended September 30, 2010. The expense represented an effective tax rate of 39.1%. The increase in our effective tax rate has resulted primarily from a difference between the tax accounting basis and the financial accounting basis associated with a hospital exchange that occurred in 2011.

Non-Controlling Interests

Non-controlling interests in consolidated earnings were $0.8 million for the three months ended September 30, 2011 compared to $0.7 million for the three months ended September 30, 2010.

Nine Months Ended September 30, 2011 Compared to Nine Months Ended September 30, 2010

In the following discussion, we address the results of operations of Select and Holdings. With the exception of interest expense, loss on early retirement of debt and income taxes, the results of operations of Holdings are identical to those of Select. Therefore, discussion related to net operating revenue, operating expenses, Adjusted EBITDA, income from operations and non-controlling interest is identical for Holdings and Select.

Net Operating Revenues

Our net operating revenues increased by 19.0% to $2,086.1 million for the nine months ended September 30, 2011 compared to $1,752.9 million for the nine months ended September 30, 2010.

Specialty Hospitals.Our specialty hospital net operating revenues increased by 26.5% to $1,561.3 million for the nine months ended September 30, 2011 compared to $1,234.6 million for the nine months ended September 30, 2010. The Regency hospitals acquired on September 1, 2010 contributed $255.0 million of net operating revenue, or $232.2 million of the increased net operating revenues. The remaining increase primarily resulted from an increase in patient volumes in our other specialty hospitals. Our patient days increased 23.0% to 994,179 days for the nine months ended September 30, 2011, which was principally related to the addition of the Regency hospitals. The Regency hospitals contributed a net increase in patient days of 143,092 days. Excluding the effect of the Regency hospitals, patient days would have increased 5.4% compared to the same period, prior year as a result of increases in both Medicare and non-Medicare volumes. The occupancy percentage increased to 71% for the nine months ended September 30, 2011 from 68% for the nine months ended September 30, 2010. Our average net revenue per patient day was $1,498 for the nine months ended September 30, 2011 compared to $1,481 for the nine months ended September 30, 2010. The increase in our net revenue per patient day was principally due to increases in our average Medicare net revenue per patient day.

46

Outpatient Rehabilitation.Our outpatient rehabilitation net operating revenues increased 1.2% to $524.7 million for the nine months ended September 30, 2011 compared to $518.3 million for the nine months ended September 30, 2010. The net operating revenues generated by our outpatient rehabilitation clinics grew approximately 2.3% compared to the nine months ended September 30, 2010. The increase was principally related to revenues we are generating from services provided to the Baylor JV. The number of patient visits in our owned outpatient rehabilitation clinics decreased 1.8% for the nine months ended September 30, 2011 to 3,381,896 visits compared to 3,442,266 visits for the nine months ended September 30, 2010. The decrease in visits, which also slowed our revenue growth, resulted primarily from the 18 clinics in the Dallas-Fort Worth metroplex that were contributed to the Baylor JV, which is accounted for as an unconsolidated joint venture. Net revenue per visit in our clinics increased 2.0% to $103 for the nine months ended September 30, 2011, compared to $101 for the nine months ended September 30, 2010. Our contract services business experienced a decline in net operating revenues of approximately 2.3% compared to the nine months ended September 30, 2010 which was the result of a loss of a significant group of locations during the second quarter of 2010 where our contract was cancelled when our customer sold its business. We were able to partially offset some of the lost net revenue through the addition of new contracts.

Operating Expenses

Our operating expenses include our cost of services, general and administrative expense and bad debt expense. Our operating expenses increased by $282.2 million to $1,796.6 million for the nine months ended September 30, 2011 compared to $1,514.4 million for the nine months ended September 30, 2010. As a percentage of our net operating revenues, our operating expenses were 86.1% for the nine months ended September 30, 2011 compared to 86.4% for the nine months ended September 30, 2010. Our cost of services, a major component of which is labor expense, were $1,708.9 million for the nine months ended September 30, 2011 compared to $1,441.2 million for the nine months ended September 30, 2010. The principal cause of this increase resulted from the addition of the Regency hospitals. Additionally facility rent expense, which is a component of cost of services, was $89.1 million for the nine months ended September 30, 2011 compared to $87.5 million for the nine months ended September 30, 2010. General and administrative expenses were 2.3% of net operating revenue or $47.7 million for the nine months ended September 30, 2011 compared to 2.4% of net operating revenue or $41.8 million for the nine months ended September 30, 2010. The increase in our general and administrative expenses for the nine months ended September 30, 2011 resulted from increased compensation costs of approximately $7.6 million primarily related to executive compensation, and increased legal expenses of approximately $7.8 million primarily related to the Columbus matter. These cost increases were offset by gains of $5.4 million on the sale of assets. Additionally, the 2010 period included a $4.8 million charge related to an increase in employee healthcare costs. Our bad debt expense as a percentage of net operating revenues was 1.9% for the nine months ended September 30, 2011 compared to 1.8% for the nine months ended September 30, 2010.

Adjusted EBITDA

Specialty Hospitals. Our specialty hospital Adjusted EBITDA increased by 27.3% to $273.0 million for the nine months ended September 30, 2011 compared to $214.5 million for the nine months ended September 30, 2010. Our Adjusted EBITDA margins increased to 17.5% for the nine months ended September 30, 2011 from 17.4% for the nine months ended September 30, 2010. For the nine months ended September 30, 2011, the Regency hospitals acquired on September 1, 2010 contributed $35.9 million of the increase in specialty hospital Adjusted EBITDA. Excluding the effect of the Regency hospitals in both periods, the Adjusted EBITDA margin would have been 18.2% and 17.8% for the nine months ended September 30, 2011 and 2010, respectively. In addition to the contribution from the Regency hospitals, the increase in the Adjusted EBITDA for the remainder of our specialty hospitals was primarily the result of the increase in patient volumes and our Medicare net revenue per patient day described above under “Net Operating Revenues — Specialty Hospitals.”

47

Outpatient Rehabilitation. Our outpatient rehabilitation Adjusted EBITDA for the segment decreased by 2.3% to $65.3 million for the nine months ended September 30, 2011 compared to $66.8 million for the nine months ended September 30, 2010. Our outpatient rehabilitation Adjusted EBITDA margins for the segment decreased to 12.4% for the nine months ended September 30, 2011 from 12.9% for the nine months ended September 30, 2010. The principal reason for the decrease in the Adjusted EBITDA margin for the segment was related to our contract services business. The Adjusted EBITDA in our outpatient rehabilitation clinics increased by $5.7 million for the nine months ended September 30, 2011 compared to the nine months ended September 30, 2010. Additionally, our Adjusted EBITDA margins for our outpatient rehabilitation clinics grew to 13.6% for the nine months ended September 30, 2011 from 12.5% for the nine months ended September 30, 2010. The increase in our Adjusted EBITDA and Adjusted EBITDA margin in our rehabilitation clinics was principally due to an improvement in the performance in the clinics acquired in 2007 from HealthSouth Corporation and the increase in our net revenue per visit. We experienced a decline in the Adjusted EBITDA and Adjusted EBITDA margin of our contract services business that resulted from the loss of a significant contract during the second quarter of 2010 as described under “Net Operating Revenues — Outpatient Rehabilitation” and higher labor costs for the treatment models required by RUGS IV/MDS 3.0 rules that became effective on October 1, 2010.

Other. The Adjusted EBITDA loss was $46.1 million for the nine months ended September 30, 2011 compared to an Adjusted EBITDA loss of $41.4 million for the nine months ended September 30, 2010 and is primarily related to our general and administrative expenses as described under “Operating Expenses.”

Income from Operations

For the nine months ended September 30, 2011 we had income from operations of $236.7 million compared to $187.2 million for the nine months ended September 30, 2010. The increase in income from operations resulted primarily from the Regency hospitals acquired on September 1, 2010 which contributed $31.0 million of income from operations for the nine months ended September 30, 2011, and improved operating performance at our other specialty hospitals, offset in part by an increase in general and administrative costs.

Loss on Early Retirement of Debt

Select Medical Corporation.On June 1, 2011 we refinanced our senior secured credit facility which consisted of an $850.0 million term loan facility and a $300.0 million revolving facility. A portion of the proceeds from this transaction were used to repay $266.5 million of our 7 5/8% senior subordinated notes. We recognized a loss on early retirement of debt of $20.4 million for the nine months ended September 30, 2011 which included the write-off of unamortized deferred financing costs and tender premiums.

Select Medical Holdings Corporation.On June 1, 2011 we refinanced our senior secured credit facility which consisted of an $850.0 million term loan facility and a $300.0 million revolving facility. A portion of the proceeds from this transaction were used to repurchase and retire $266.5 million of Select’s 7 5/8% senior subordinated notes and $150.0 million to repurchase and retire our 10% senior subordinated notes. In connection with the refinancing, we recognized a loss on early retirement of debt of $31.0 million for the nine months ended September 30, 2011 which included the write-off of unamortized deferred financing costs, tender premiums and original issue discount.

48

Interest Expense

Select Medical Corporation.Interest expense was $59.9 million for the nine months ended September 30, 2011 compared to $66.2 million for the nine months ended September 30, 2010. The decrease in interest expense resulted primarily from the expiration of interest rate swaps in 2010 that carried higher fixed interest rates, which was offset in part by the effects of the repayment of $150.0 million of Holdings’ debt, for which Select was not previously obligated, which was refinanced at Select through indebtedness incurred under the new senior secured credit facility on June 1, 2011.

Select Medical Holdings Corporation.Interest expense was $75.1 million for the nine months ended September 30, 2011 compared to $87.0 million for the nine months ended September 30, 2010. The decrease in interest expense resulted primarily from the expiration of interest rate swaps in 2010 that carried higher fixed interest rates and lower interest rates on the portions of the debt that were refinanced on June 1, 2011.

Income Taxes

Select Medical Corporation.We recorded income tax expense of $65.9 million for the nine months ended September 30, 2011. The expense represented an effective tax rate of 41.7%. We recorded income tax expense of $47.3 million for the nine months ended September 30, 2010. The expense represented an effective tax rate of 39.0%. Select Medical Corporation is part of the consolidated federal tax return for Select Medical Holdings Corporation. We allocate income taxes between Select and Holdings for purposes of financial statement presentation. Because Holdings is a passive investment company incorporated in Delaware, it does not incur any state income tax expense or benefit on its specific income or loss and, as such, receives a tax allocation equal to the federal statutory rate of 35% on its specific income or loss. Based upon the relative size of Holdings’ income or loss, this can cause the effective tax rate for Select to differ from the effective tax rate for the consolidated company. The analysis in the following paragraph discusses the change in our consolidated tax rate.

Select Medical Holdings Corporation.We recorded income tax expense of $56.8 million for the nine months ended September 30, 2011. The expense represented an effective tax rate of 43.0%. We recorded income tax expense of $40.0 million for the nine months ended September 30, 2010. The expense represented an effective tax rate of 39.8%. The increase in our effective tax rate has resulted primarily from a difference between the tax accounting basis and the financial accounting basis associated with a hospital exchange that occurred in 2011 and an increase in our reserves for uncertain tax positions resulting from the settlement costs associated with the Columbus matter.

Non-Controlling Interests

Non-controlling interests in consolidated earnings were $4.4 million for the nine months ended September 30, 2011 compared to $3.8 million for the nine months ended September 30, 2010.

49

Liquidity and Capital Resources

Cash Flows for the Nine Months Ended September 30, 2011 and Nine Months Ended September 30, 2010

	Select Medical Holdings
	Corporation						Select Medical Corporation
	Nine Months						Nine Months
	Ended September 30,						Ended September 30,
	2010			2011			2010			2011
	(in thousands)						(in thousands)
Cash flows provided by operating activities	$	110,265		$	143,914		$	135,787		$	166,834
Cash flows used in investing activities		(204,428	)		(35,808	)		(204,428	)		(35,808	)
Cash flows provided by (used in) financing activities		25,826			(102,258	)		304			(125,178	)
Net increase (decrease) in cash and cash equivalents		(68,337	)		5,848			(68,337	)		5,848
Cash and cash equivalents at beginning of period		83,680			4,365			83,680			4,365
Cash and cash equivalents at end of period	$	15,343		$	10,213		$	15,343		$	10,213

Operating activities for Select provided $166.8 million of cash flows for the nine months ended September 30, 2011. Our days sales outstanding were 52 days at September 30, 2011 compared to 47 days at September 30, 2010 and 51 days at December 31, 2010. The increase in days sales outstanding between September 30, 2010 and September 30, 2011 is primarily related to the timing of the periodic interim payments we receive from Medicare for the services provided at our specialty hospitals.

The operating cash flows of Select exceeded the operating cash flows of Holdings by $22.9 million for the nine months ended September 30, 2011 and by $25.5 million for the nine months ended September 30, 2010. The difference relates to interest payments associated with Holdings’ indebtedness.

Investing activities for Select and Holdings used $35.8 million of cash flow for the nine months ended September 30, 2011. The principal use of cash included $32.1 million related to the purchase of property and equipment and $13.5 million related to the purchase of the Baylor JV partnership units and working capital advances, offset by proceeds from the sale of assets of $7.9 million, which was primarily related to the sale of a building we acquired in connection with the acquisition of Regency and $1.9 million from acquisition activities that includes the post-closing settlement of the Regency net working capital adjustment with the seller. Investing activities used $204.4 million of cash flow for the nine months ended September 30, 2010. The use of cash included acquisition payments of $165.8 million related principally to the acquisition of Regency, and $38.6 million for the purchase of property and equipment.

Financing activities for Select used $125.2 million of cash flow for the nine months ended September 30, 2011. The primary use of cash related to dividends paid to Holdings of $204.6 million to fund interest payments and the repurchase of all $150.0 million principal amount of Holdings 10% senior subordinated notes, $18.6 million of debt issuance costs, repayment of bank overdrafts of $4.2 million and $3.5 million in distributions to non-controlling interests offset by net borrowings of debt of $105.5 million. Financing activities provided $0.3 million of cash flow for the nine months ended September 30, 2010. The primary source of cash related to net borrowings on our revolving credit facility of $20.0 million and proceeds from bank overdrafts of $11.0 million which were offset by dividends paid to Holdings to fund interest payments of $25.5 million, $3.6 million in distributions to non-controlling interests, and net payments related to seller and other debt of $1.7 million.

50

The difference in cash flows provided by financing activities of Holdings compared to Select of $22.9 million for the nine months ended September 30, 2011 and $25.5 million for the nine months ended September 30, 2010 relates to dividends paid by Select to Holdings to service Holdings’ interest obligations related to indebtedness.

Capital Resources

Select Medical Corporation.Select had net working capital of $110.4 million at September 30, 2011 compared to net working capital deficit of $73.5 million at December 31, 2010. The increase in net working capital is primarily due to a decrease in our current portion of long-term debt resulting from our debt refinancing on June 1, 2011 and an increase in our accounts receivable.

Select Medical Holdings Corporation.Holdings had net working capital of $110.0 million at September 30, 2011 compared to net working capital deficit of $70.2 million at December 31, 2010. The increase in net working capital is primarily due to a decrease in our current portion of long-term debt resulting from our debt refinancing on June 1, 2011 and an increase in our accounts receivable.

On June 1, 2011, Select entered into a new senior secured credit agreement (the “Credit Agreement”) that provides for $1.15 billion in senior secured credit facilities (“Senior Secured Credit Facilities”) comprised of an $850.0 million, seven-year term loan facility (“Term Loan”) and a $300.0 million, five-year revolving credit facility (“Revolving Credit Facility”), including a $75.0 million sublimit for the issuance of standby letters of credit and a $25.0 million sublimit for swingline loans. Borrowings under the Senior Secured Credit Facilities are guaranteed by Holdings and substantially all of Select’s current domestic subsidiaries and will be guaranteed by Select’s future domestic subsidiaries and secured by substantially all of Select’s existing and future property and assets and by a pledge of Select’s capital stock, the capital stock of Select’s domestic subsidiaries and up to 65% of the capital stock of Select’s foreign subsidiaries, if any.

Borrowings under the Senior Secured Credit Facilities will bear interest at a rate equal to:

• in the case of the Term Loan, Adjusted LIBO plus 3.75%, or Alternative Base Rate plus 2.75%; and

• in the case of the Revolving Credit Facility, Adjusted LIBO plus a percentage ranging from 2.75% to 3.75%, or Alternative Base Rate plus a percentage ranging from 1.75% to 2.75%, in each case based on Select’s leverage ratio.

“Adjusted LIBO” is defined as, with respect to any interest period, the London interbank offered rate for such interest period, adjusted for any applicable statutory reserve requirements; provided that Adjusted LIBO, when used in reference to the Term Loan, will at no time be less than 1.75% per annum.

“Alternative Base Rate” is defined as the highest of (a) the administrative agent’s Prime Rate, (b) the Federal Funds Effective Rate plus 1/2 of 1.00% and (c) the Adjusted LIBO from time to time for an interest period of one month, plus 1.00%.

51

The applicable margin percentage for revolving loans will decrease from (1) 2.75% to 2.50% for alternate base rate loans and (2) 3.75% to 3.50% for adjusted LIBOR loans upon the delivery of Select’s Form 10-Q to JP Morgan Chase Bank, N.A., as administrative agent to Select’s senior secured credit facility.

The Term Loan amortizes in equal quarterly installments on the last day of each March, June, September and December in aggregate annual amounts equal to $2.1 million. The balance of the Term Loan will be payable on June 1, 2018, provided that if on the 90th day prior to the scheduled final maturity date of Select’s 7 5/8% senior subordinated notes due 2015 (the “Tranche B Trigger Date”) more than $60.0 million in aggregate principal amount of Select’s 7 5/8% senior subordinated notes due 2015 are outstanding, the maturity date for the Term Loan will be the Tranche B Trigger Date. Similarly, the Revolving Credit Facility will be payable on June 1, 2016, provided that if on the 90th day prior to the scheduled final maturity date of Select’s 7 5/8% senior subordinated notes due 2015 (the “Revolving Trigger Date”) more than $60.0 million in aggregate principal amount of Select’s 7 5/8% senior subordinated notes due 2015 are outstanding, the maturity date for the Revolving Credit Facility will be the Revolving Trigger Date.

Select will be required to prepay borrowings under the Senior Secured Credit Facilities with (1) 100% of the net cash proceeds received from non-ordinary course asset sales or other dispositions, or as a result of a casualty or condemnation, subject to reinvestment provisions and other customary carveouts and the payment of certain indebtedness secured by liens subject to a first lien intercreditor agreement, (2) 100% of the net cash proceeds received from the issuance of debt obligations other than certain permitted debt obligations, and (3) 50% of excess cash flow (as defined in the Credit Agreement) if Select’s leverage ratio is greater than 3.75 to 1.00 and 25% of excess cash flow if Select’s leverage ratio is less than or equal to 3.75 to 1.00 and greater than 3.25 to 1.00, in each case, reduced by the aggregate amount of term loans optionally prepaid during the applicable fiscal year. Select will not be required to prepay borrowings with excess cash flow if Select’s leverage ratio is less than or equal to 3.25 to 1.00.

The Senior Secured Credit Facilities require Select to maintain a leverage ratio (based upon the ratio of indebtedness for money borrowed to consolidated EBITDA, as defined in the Credit Agreement), which is tested quarterly, and prohibits Select from making capital expenditures in excess of $125.0 million in any fiscal year (subject to a 50% carry-over provision). As of September 30, 2011, Select was required to maintain its leverage ratio at less than 6.00 to 1.00, and Select’s leverage ratio was 3.44 to 1.00 as of September 30, 2011. Failure to comply with these covenants would result in an event of default under the Senior Secured Credit Facilities and, absent a waiver or an amendment from the lenders, preclude Select from making further borrowings under the Revolving Credit Facility and permit the lenders to accelerate all outstanding borrowings under the Senior Secured Credit Facilities.

The Senior Secured Credit Facilities also contain a number of affirmative and restrictive covenants, including limitations on mergers, consolidations and dissolutions; sales of assets; investments and acquisitions; indebtedness; liens; affiliate transactions; and dividends and restricted payments. The Senior Secured Credit Facilities contain events of default for non-payment of principal and interest when due, cross-default and cross-acceleration provisions and an event of default that would be triggered by a change of control.

Select used borrowings under the Senior Secured Credit Facilities to refinance all of its outstanding indebtedness under its existing credit facilities, to repurchase $266.5 million aggregate principal amount of its 7 5/8% senior subordinated notes due 2015 and to repay all of Holdings’ existing 10% senior subordinated notes due 2015.

As of September 30, 2011, we had $217.2 million of availability under our Revolving Credit Facility (after giving effect to $32.8 million of outstanding letters of credit).

52

We may from time to time seek to retire or purchase our outstanding debt through cash purchases and/or exchanges for equity securities, in open market purchases, in tender offers, privately negotiated transactions or otherwise. Such repurchases or exchanges, if any, may be funded from operating cash flows or other sources and will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. The amounts involved may be material.

Holdings has authorized a program to repurchase up to $150.0 million worth of shares of our common stock. The program will remain in effect until March 31, 2013, unless extended by the board of directors. Through September 30, 2011, Holdings has repurchased 11,555,447 shares at a cost of $75.8 million, which includes related transaction costs. We anticipate funding this program through available operating cash flow and borrowings under our senior secured credit facility.

We believe our internally generated cash flows and borrowing capacity under our senior secured credit facility will be sufficient to finance operations over the next twelve months.

As a result of the SCHIP Extension Act as amended by PPACA, which prohibits the establishment and classification of new LTCHs or satellites during the five calendar years commencing on December 29, 2007, we have stopped all new LTCH development. However, we continue to evaluate opportunities to develop new joint venture relationships with significant health systems, and from time to time we may also develop new inpatient rehabilitation hospitals. We also intend to open new outpatient rehabilitation clinics in local areas that we currently serve where we can benefit from existing referral relationships and brand awareness to produce incremental growth. In addition to our development activities, we may grow our network of specialty hospitals through opportunistic acquisitions.

Inflation

The healthcare industry is labor intensive. Wages and other expenses increase during periods of inflation and when labor shortages occur in the marketplace. In addition, suppliers pass along rising costs to us in the form of higher prices. We have implemented cost control measures, including our case and resource management program, to curtail increases in operating costs and expenses. We cannot predict our ability to cover or offset future cost increases.

Recent Accounting Pronouncements

In May 2011, FASB issued Accounting Standards Update (“ASU”) 2011-04, “Fair Value Measurement (Topic 820) — Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs” (“Update 2011-04”). Update 2011-04 generally represents clarification of Topic 820, but also includes instances where a particular principle or requirement for measuring fair value or disclosing information about fair value measurements has changed. Update 2011-04 results in common principles and requirements for measuring fair value and for disclosing information about fair value measurements in accordance with GAAP and International Financial Reporting Standards. Update 2011-04 is effective for interim and annual periods beginning after December 15, 2011 and is to be applied prospectively. Early application is not permitted. We do not expect the adoption of Update 2011-04 to have a material impact on our consolidated financial statements.

53

In June 2011, FASB issued ASU 2011-05, “Comprehensive Income (Topic 220) — Presentation of Comprehensive Income” (“Update 2011-05”) that improves the comparability, consistency, and transparency of financial reporting and increases the prominence of items reported in other comprehensive income by eliminating the option to present components of other comprehensive income as part of the statement of changes in stockholders’ equity. Update 2011-05 requires that all non-owner changes in stockholders’ equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. Under either method, adjustments must be displayed for items that are reclassified from other comprehensive income (“OCI”) to net income, in both net income and OCI. Update 2011-05 does not change the current option for presenting components of OCI gross or net of the effect of income taxes, provided that such tax effects are presented in the statement in which OCI is presented or disclosed in the notes to the financial statements. Additionally, Update 2011-05 does not affect the calculation or reporting of earnings per share. Update 2011-05 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2011 and is to be applied retrospectively, with early adoption permitted. The adoption of Update 2011-05 will cause us to change our presentation of other comprehensive income on our consolidated financial statements.

In July 2011, the FASB issued ASU 2011-07, “Health Care Entities (Topic 954): Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts and the Allowance for Doubtful Accounts for Certain Health Care Entities” (“Update 2011-07”). Update 2011-07 requires certain health care entities to change the presentation in their statement of operations by reclassifying the provision for bad debts associated with patient service revenue from an operating expense to a deduction from patient service revenue (net of contractual allowances and discounts). Additionally, those health care entities are required to provide enhanced disclosure about their policies for recognizing revenue and assessing bad debts. The amendments also require disclosures of patient service revenue (net of contractual allowances and discounts) as well as qualitative and quantitative information about changes in the allowance for doubtful accounts. Update 2011-07 is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2011, with early adoption permitted. We are in the process of evaluating the effects of Update 2011-07 on our consolidated financial statements.

In September 2011, the FASB issued ASU 2011-08, “Intangibles — Goodwill and Other (Topic 350): Testing Goodwill for Impairment” (“Update 2011-08). Update 2011-08 allows an entity to first assess qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill impairment test. Under Update 2011-08, an entity would not be required to calculate the fair value of a reporting unit unless the entity determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. Update 2011-08 includes a number of events and circumstances for an entity to consider in conducting the qualitative assessment. Update 2011-08 will be effective for goodwill impairment test performed for fiscal years beginning after December 15, 2011. Update 2011-08 does not change the accounting or measurement of impairments. This update will have no effect on our consolidated financial statements.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Quantitative and Qualitative Disclosures About Market Risk

We are subject to interest rate risk in connection with our long-term indebtedness. Our principal interest rate exposure relates to the loans outstanding under Select’s senior secured credit facility and Holdings’ senior floating rate notes. As of September 30, 2011, Select had $897.9 million in term and revolving loans outstanding under its senior secured credit facility, excluding the unamortized debt discount of $8.1 million, and Holdings had $167.3 million in senior floating rate notes outstanding, which bear interest at variable rates. Each eighth point change in interest rates on the variable rate portion of our long-term indebtedness would result in a $1.3 million annual change in interest expense. However, because the variable interest rate for our $847.9 million in term loans is subject to an Adjusted LIBO Rate floor of 1.75%, until the Adjusted LIBO Rate exceeds 1.75%, our interest rate on this indebtedness is effectively fixed at 5.50%.

54

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We carried out an evaluation, under the supervision and with the participation of our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934) as of the end of the period covered in this report. Based on this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures, including the accumulation and communication of disclosure to our principal executive officer and principal financial officer as appropriate to allow timely decisions regarding disclosure, are effective as of September 30, 2011 to provide reasonable assurance that material information required to be included in our periodic SEC reports is recorded, processed, summarized and reported within the time periods specified in the relevant SEC rules and forms.

Changes in Internal Control Over Financial Reporting

There was no change in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Securities Exchange Act of 1934) identified in connection with the evaluation required by Rule 13a-15(d) of the Securities Exchange Act of 1934 that occurred during the third quarter ended September 30, 2011 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Inherent Limitations on Effectiveness of Controls

It should be noted that any system of controls, however well designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of the system will be met. In addition, the design of any control system is based in part upon certain assumptions about the likelihood of future events. Because of these and other inherent limitations of control systems, there is only reasonable assurance that our controls will succeed in achieving their goals under all potential future conditions.

PART II OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

To cover claims arising out of the operations of the Company’s specialty hospitals and outpatient rehabilitation facilities, the Company maintains professional malpractice liability insurance and general liability insurance. The Company also maintains umbrella liability insurance covering claims which, due to their nature or amount, are not covered by or not fully covered by the Company’s other insurance policies. These insurance policies also do not generally cover punitive damages and are subject to various deductibles and policy limits. Significant legal actions as well as the cost and possible lack of available insurance could subject the Company to substantial uninsured liabilities.

The Company is subject to legal proceedings and claims that arise in the ordinary course of business, which include malpractice claims covered under insurance policies, subject to a self-insured retention of $2.0 million per medical incident for professional liability claims and $2.0 million per occurrence for general liability claims. In the Company’s opinion, the outcome of these actions will not have a material adverse effect on its financial position or results of operations.

55

Healthcare providers are subject to lawsuits under thequi tamprovisions of the federal False Claims Act.Qui tamlawsuits typically remain under seal (hence, usually unknown to the defendant) for some time while the government decides whether or not to intervene on behalf of a privatequi tamplaintiff (known as a relator) and take the lead in the litigation. These lawsuits can involve significant monetary damages and penalties and award bounties to private plaintiffs who successfully bring the suits. The Company has been a defendant in these cases in the past, and may be named as a defendant in similar cases from time to time in the future.

During the third quarter of 2011, the Company entered into a settlement agreement with the United States government in connection with the previously disclosedqui tamlawsuit filed in Columbus, Ohio against certain subsidiaries of the Company. The lawsuit, filed under seal in September 2007, led to the Company’s receiving, in July 2009, a subpoena from the government seeking various documents concerning the Company’s financial relationships with certain physicians practicing at its long term acute care hospitals in Columbus, Ohio. Under the terms of the settlement, the Company agreed to pay $7.5 million to the government and enter into a 5-year corporate integrity agreement covering its long term acute care hospitals. The Company also agreed to pay certain legal fees of thequi tamrelator’s counsel. In the settlement agreement, the Company admitted no liability or wrongdoing. During the second quarter of 2011, the Company recorded a pre-tax charge of $7.5 million to establish a settlement reserve in connection with the matter. The settlement amounts and counsel fees were paid in full during the third quarter of 2011, and the Company does not expect to incur any additional material charges in connection with this matter.

ITEM 1A. RISK FACTORS.

There have been no material changes from our risk factors as previously reported in our Annual Report on Form 10-K for the year ended December 31, 2010.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Purchases of Equity Securities by the Issuer

In November 2010, our board of directors authorized a stock repurchase program pursuant to which we may purchase up to $100.0 million worth of our common stock. On August 3, 2011, our board of directors authorized an increase of $50.0 million in the capacity of our common stock repurchase program, from $100.0 million to $150.0 million. The other terms of the plan remain unchanged. The program will now remain in effect until March 31, 2013, unless extended by our board of directors. In the three months ended September 30, 2011, we purchased a total of 4,239,972 shares of our common stock at an average purchase price of $6.67. The following table sets forth the monthly purchases made under this program during the three months ended September 30, 2011:

					Total
					Number of		Approximate
					Shares		Dollar Value of
					Purchased		Shares that
					as Part of		May Yet Be
	Total		Average		Publicly		Purchased
	Number		Price		Announced		Under the
	of Shares		Paid Per		Plans or		Plans or
Period	Purchased		Share		Programs		Programs
July 1, 2011 to July 31, 2011		—		—		—	$	52,571,798
August 1, 2011 to August 31, 2011		1,438,760	$	6.20		1,438,760	$	93,622,314
September 1, 2011 to September 30, 2011		2,801,212	$	6.91		2,801,212	$	74,215,982

56

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

Not applicable.

ITEM 4. REMOVED AND RESERVED

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

The exhibits to this report are listed in the Exhibit Index appearing on page 58 hereof.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

SELECT MEDICAL CORPORATION
By:	/s/ Martin F. Jackson
	Martin F. Jackson
	Executive Vice President and Chief Financial Officer (Duly Authorized Officer)
By:	/s/ Scott A. Romberger
	Scott A. Romberger
	Senior Vice President, Chief Accounting Officer and Controller (Principal Accounting Officer)

Dated: November 3, 2011

SELECT MEDICAL HOLDINGS CORPORATION
By:	/s/ Martin F. Jackson
	Martin F. Jackson
	Executive Vice President and Chief Financial Officer (Duly Authorized Officer)
By:	/s/ Scott A. Romberger
	Scott A. Romberger
	Senior Vice President, Chief Accounting Officer and Controller (Principal Accounting Officer)

Dated: November 3, 2011

57

EXHIBIT INDEX — OPEN

Exhibit		Description
	31.1	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
	31.2	Certification of Executive Vice President and Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
	32.1	Certification of Chief Executive Officer, and Executive Vice President and Chief Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

58